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ABSTRACT 
In two separate studies, the present research investigated two factors 
noted to have opposing regulatory actions on follicle activation: KL, which is 
thought to promote follicle activation, and AMH, known to inhibit follicle 
activation.  With respect to regulation and function, there has been little 
study of either factor in the hen ovary.  The domestic hen ovary, with its 
highly regulated follicle hierarchy, is a useful animal model for study of 
folliculogenesis.  Our goal was to characterize the mRNA expression pattern 
of kit ligand (KL) throughout follicle development, as well as examine 
regulation and function of the Kit system in the hen ovary.  Additionally, we 
examined the effects of bioactive chicken AMH on granulosa cell mRNA 
expression of FSHR and steroid production. 
In the first study, the highest levels of steady-state KL mRNA 
expression were seen in the very small (<1 mm) follicles and 3-5 mm follicle 
granulosa cells, with lower levels seen in the larger, selected follicles 
(p<0.001).  There was no difference seen in KL mRNA expression between 
granulosa cells from the germinal disc region versus the non-germinal disc 
region.  With regard to regulation, KL mRNA expression was examined 
following various treatments of granulosa cell culture.  KL expression in 
granulosa cells from 6-8 mm follicles was shown to be increased by 
treatment with oocyte-conditioned medium (OCM), vitamin D3, and FSH.  
KL mRNA expression was unaffected by treatment with testosterone, 
progesterone and estradiol.  With respect to function, the Kit system appears 
to regulate granulosa cell progesterone production from the large follicles, 
but has no influence on theca estradiol production or on granulosa cell 
 
 
proliferation.  Expression of cKit protein was observed in <1 mm follicles, 
theca tissue, and ovarian body, but was not seen in granulosa cells. 
In the second study, we examined effects of bioactive chicken AMH 
(in the form of TCM, testis conditioned media) on granulosa cell mRNA 
expression of FSHR.  TCM consistently decreased granulosa cell FSHR 
mRNA expression in 3-5 mm and 9-16 mm follicles, but we were unable to 
determine the specificity of this effect using an AMH antibody.  TCM 
increased granulosa cell proliferation, indicating downregulation of FSHR 
mRNA was not due to adverse effects on the granulosa cells.  TCM 
treatment significantly decreased granulosa cell progesterone production, but 
this was not blocked by AMH antibody.  Our results show that TCM 
contains a bioactive substance which regulates granulosa cell function, and 
suggest that this substance is not AMH.  However, it is possible that the 
antibody against AMH did not completely immunoneutralize the AMH 
present in TCM, so we are hesitant to rule out the possibility that our results 
are due to bioactive AMH. 
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1 ACTIONS OF THE KIT SYSTEM IN THE OVARY 
Functionality of the Kit system, composed of Kit ligand (KL) and its 
cognate tyrosine kinase receptor, cKit, has been shown to be essential in a 
variety of tissues and processes (Hutt et al., 2006).  KL is a cytokine that has 
two primary isoforms (soluble and membrane-spanning), synthesized from 
two alternatively spliced forms of mRNA that differ in the presence of exon 
6. This exon has been shown to encode a cleavage site involved in 
proteolysis of soluble KL (Huang et al., 1992).  KL initiates its biological 
activity by binding the cKit receptor in its extracellular domain (Lemmon et 
al., 1997; Roskoski, 2005).  There is also evidence of a soluble form of cKit 
that consists of part of the extracellular domain.  This form, detected in 
human serum, (Wypych et al., 1995) follicular fluid, (Tanikawa et al., 1998) 
and endothelial cells, (Broudy et al., 1994) binds KL with high affinity and 
could prevent its binding with the membrane-associated cKit.  Functions of 
the Kit system found in the chicken include proliferation of normal 
haemopoeitic cells (Hayman et al., 1993; Larsen et al., 1993), proliferation and 
differentiation of neural crest-derived melanocytes (Lahav et al., 1994), 
differentiation and functional activation of osteoclasts (Van’t Hof et al., 
1997), and assisting in the survival of dorsal root ganglia neurons in vitro 
(Carnahan et al., 1994).  There has been limited examination of the KL/cKit 
system in the ovary of chickens. 
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Kit Ligand Expression 
In the chicken, the soluble and longer isoform of KL is a 287 amino 
acid polypeptide that was cloned from a chicken brain cDNA library.  
Northern blot hybridization showed the presence of KL RNA in many 
tissues including the brain, bursa, heart, kidney, spleen, thymus, ovary, and 
testis.  Chicken KL shows 53% identity with mouse and 52% identity with 
human KL (Zhou et al., 1993; Petitte and Kulik, 1996).  Although KL 
expression throughout follicle development in the chicken ovary is currently 
unreported, four isoforms of one chicken KL gene have been identified and 
cloned: KL-1, KL-2, KL-3 and KL-4.  KL-1 (the soluble isoform) was 
reported to be predominantly expressed in the chicken ovary (Wang et al., 
2007). 
The ovarian expression pattern of KL mRNA and protein has been 
well studied in mammals.  In the mouse, KL protein and mRNA was 
detected in follicle granulosa cells at all stages of development, with low 
expression found in primordial follicles and then increasing with follicle 
growth to the highest levels in preantral follicles.  KL expression then 
decreases to low levels in cumulus cells of antral follicles, while remaining 
high in mural granulosa cells (Manova et al., 1993; Motro and Bernstein, 
1993).  KL protein was also detected in mouse oocytes, thought to be an 
outcome of receptor-mediated endocytosis (Manova et al., 1993; Jahn et al., 
2002; Kang et al., 2003).  In goats, KL protein and mRNA were expressed in 
granulosa cells at all stages of development in addition to corpus luteum and 
epithelium (Silva et al., 2006); the highest level of steady-state KL mRNA 
expression was found in secondary follicles (Celestino et al., 2010).  Similarly, 
granulosa cell KL mRNA expression has been shown in the rat (Ismail et al., 
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1996), sheep, (Tisdall et al., 1999) human (Hoyer et al., 2005) and pig 
(Brankin et al., 2004).  Additionally, KL protein has been localized to the 
granulosa layer in human primordial follicles using in situ hybridization 
(Carlsson et al., 2006). 
Regulation of Kit Ligand 
The gonadotropins, as well as paracrine and autocrine factors, have 
been found to play a part in the regulation of KL in mammalian 
reproduction.  In one study, four hours after hCG stimulation of PMSG-
treated mice, KL mRNA expression was increased in preovulatory granulosa 
cells.  This increase in KL mRNA occurred in both mural and cumulus 
granulosa cells, with predominant expression found in mural granulosa cells.  
Additionally, an increase in KL protein was seen in mural but not cumulus 
cells at four hours following hCG stimulation (Ye et al., 2009).  Similarly, six 
hours after hCG stimulation in PMSG-primed rats, KL mRNA was elevated 
in whole ovaries and in granulosa cells (Ismail et al., 1996).  The same effect 
of increased KL mRNA occured after culturing granulosa cells with hCG in 
the cow (Parrott and Skinner, 1998).  FSH also significantly increased KL 
mRNA expression in bovine granulosa cell cultures, to the same level found 
after hCG treatment (Parrott and Skinner, 1998).  The stimulatory effect of 
FSH on KL (both isoforms) mRNA expression in preantral granulosa cell 
culture was shown to be dose responsive in mice (Joyce et al., 1999).  This 
effect was diminished with addition of partly grown oocytes and drastically 
reduced with fully grown oocytes (Joyce et al., 1999).  This study also 
demonstrated an increase in granulosa cell KL mRNA expression after 
testosterone treatment, an effect amplified by the addition of FSH (Joyce et 
al., 1999).  Other research using mice found no effect on soluble KL mRNA 
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with FSH treatments and increased membrane-bound KL mRNA with low 
(but not high) FSH treatment (Thomas et al., 2005).  In contrast, in human 
granulosa-luteal cell cultures, FSH treatment was shown to significantly 
decrease KL mRNA expression (Laitinen et al., 1995). 
With respect to paracrine regulation of KL, GDF9 and BMP15 are 
two oocyte-derived factors shown to affect KL in alternate ways.  In murine 
cumulus granulosa cell cultures, fully grown oocytes can inhibit KL mRNA 
expression.  It was suggested that this was due to GDF9, which has been 
shown to negatively regulate KL when added to preantral granulosa cell 
cultures (Joyce et al., 2000; Elvin et al., 1999).  Although the effects on KL 
granulosa cell mRNA that can be attributed solely to BMP15 are unknown, 
granulosa cells co-cultured with oocytes and BMP15 showed significantly 
increased KL mRNA compared to granulosa cells cultured alone (rat: 
Otsuka and Shimasaki, 2002; mouse: Thomas et al., 2005).  In other studies, 
addition of partly grown oocytes to mouse preantral granulosa cell culture 
promotes KL mRNA expression, (Joyce et al., 1999) hypothesized to be due 
to the presence of BMP15 in the oocytes (Joyce et al., 2000).  Treatment with 
another oocyte-derived factor, bFGF, resulted in elevated KL mRNA 
expression in cultured whole ovaries in the rat (Nilsson and Skinner, 2004). 
Paracrine regulation of KL by factors secreted from the theca cell 
layer has also been examined.  Bovine studies have indicated that treatment 
of cultured granulosa cells with keratinocyte growth factor (KGF) or 
hepatocyte growth factor (HGF), two proteins secreted by theca cells, will 
upregulate KL granulosa cell mRNA expression (Parrott and Skinner, 1998).  
Autocrine and/or paracrine regulation of KL by Leukemia inhibitory factor 
(LIF) was studied in the rat.  LIF protein is predominantly expressed in the 
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granulosa cells in primordial and primary follicles, a pattern that changes 
with growth to the pre-antral and antral follicle stages, when LIF is primarily 
expressed in the oocyte (Nilsson et al., 2002).  Treatments of granulosa cell 
cultures with LIF resulted in increased KL mRNA expression (Nilsson et al., 
2002).  A recent study examined the function of fibroblast growth factor 7 
(FGF7), found in theca and granulosa cells.  When bovine cumulus-oocyte 
complexes (COCs) were cultured with granulosa cells treated with FGF7 an 
increase in KL mRNA expression was found (Cho et al., 2008).  Although 
granulosa cell-derived AMH had no direct effect on KL gene expression, the 
stimulatory effects of KL on rat primordial follicle development were 
inhibited by AMH added to whole ovary culture.  This suggests that AMH 
could act in an autocrine manner to regulate KL activity (Nilsson et al., 
2007). 
A single study that investigated regulation of KL in the chicken ovary 
revealed that heparin binding EGF-like growth factor (HB-EGF) treatment 
resulted in a dose-dependent decrease of granulosa cell KL mRNA.  This 
inhibitory effect was seen in undifferentiated granulosa cells from 3 mm and 
6 mm follicles, and differentiated cells from F4+5 and F1; the maximal 
effect was found with 20 ng/mL HB-EGF treatments in all cases.  
Granulosa cell expression of chicken KL-1 and KL-3 were examined in this 
study; both isoforms showed the same pattern of regulation by HB-EGF, 
although KL-1 mRNA expression was much greater (Wang et al., 2007). 
Regulatory Functions of KL 
With regard to reproduction, studies in mammals have shown that the 
Kit system is involved in signaling between the oocyte and somatic cells 
during the process of follicle maturation.  KL is one of a few factors with an 
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established role in the continuous and gradual recruitment of follicles from 
the resting pool (mouse: Yoshida et al., 1997; hamster: Wang and Roy, 2004).  
It is hypothesized to be sufficient in inducing primordial follicle activation in 
the cow (Parrott and Skinner, 1997; Muruvi and Fortune, 2009) and goat 
(Celestino et al., 2010), but recent work in the mouse suggests it is 
dispensable (John et al., 2009).  KL also has the ability to provoke first polar 
body extrusion in murine preovulatory denuded oocytes, suggesting direct 
effects on its receptor (Ye et al., 2009).   
As a growth factor, KL induces proliferation of mouse preantral 
granulosa cells (Reynaud et al., 2000), an effect postulated to be mediated by 
GDF9 or BMP15 (Gilchrist et al., 2004; Otsuka et al., 2000).  While BMP15 
(plus oocytes) treatment can increase KL as discussed previously, KL 
subsequently decreases oocyte mRNA expression of BMP15, creating a 
paracrine negative feedback loop between the oocyte and granulosa cell layer 
(Otsuka and Shimasaki, 2002; Thomas et al., 2005).  Effects of KL on basic 
FGF (bFGF), another oocyte factor, have also been examined.  Results from 
one study showed that KL was able to stimulate bFGF oocyte expression 
(Jin et al., 2005), while another study found no difference in whole ovary 
bFGF expression, but did show that the ability of KL to increase the 
primordial to primary follicle transition was blocked with antibody to bFGF 
(Nilsson and Skinner, 2004). 
KL also displays a variety of paracrine effects on the theca cell layer.  
Treatment of intact mouse preantral follicle cultures with KL increased 
thecal testosterone output (Reynaud et al., 2000).  Studies of cow ovaries 
showed that KL treatment resulted in theca cell proliferation (Parrott and 
Skinner, 1997), in addition to an increase of KGF and HGF mRNA 
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expression (Parrott and Skinner, 1998).  As previously stated, these factors in 
turn upregulate KL expression, forming a positive feedback loop (Parrott 
and Skinner, 1998).  Interestingly, KL is also thought to have a regulatory 
effect on theca cell differentiation.  In rats, theca cell precursor 
differentiation in whole ovary cultures was induced by treatment with 
follicle-conditioned medium (created from preantral follicles incubated for 
two days), an effect blocked by the addition of KL antibody (Huang et al., 
2001).  Further study of KL-treated rat ovaries showed an increase (mRNA 
and protein) of steroidogenesis-related factors SF-1, StAR, and P450 
aromatase, in parallel with an inhibition of FSHR expression (Jin et al., 2005).   
cKit Expression 
The 960 amino acid sequence of chicken cKit showed 63% identity to 
mouse cKit.  Furthermore, the 5.5-kb chicken mRNA transcript was detected 
in many organs including the brain, bursa, heart, kidney, spleen, thymus, ovary, 
and testis (Sasaki et al., 1993).  Whereas the ovarian expression pattern of cKit 
in the chicken has not been established, cKit protein and mRNA expression 
was shown in oocytes of mice (Motro and Bernstein, 1993; Horie et al., 1991; 
Ye et al., 2009), sheep (Clark et al., 1996; Tisdall et al., 1999), goats (Silva et al., 
2006), pigs (Brankin et al., 2004), and humans (Horie et al., 1991, Horie et al., 
1993; Carlsson et al., 2006).  Expression was also found in theca of mice 
(Motro and Bernstein, 1993; Kang et al., 2003), pigs (Brankin et al., 2004), and 
cattle (Parrott and Skinner, 1997).  In humans, expression of cKit is also seen 
in granulosa cells from primordial (protein: Hoyer et al., 2005), secondary 
(protein: Carlsson et al., 2006), and preovulatory follicles (mRNA: Tanikawa et 
al., 1998).  As previously stated, a soluble cKit has also been found in human 
follicular fluid (Tanikawa et al., 1998).  Although cKit is predominantly 
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expressed in murine oocytes, a low level of mRNA expression was discovered 
in cumulus and mural granulosa cells (Ye et al., 2009). 
cKit Function and Regulation 
The cKit receptor must bind to its ligand to become biologically 
activated; therefore functionality of cKit (membrane-bound) is dependent on 
interactions with KL.  With respect to reproduction, binding of granulosa 
cell KL to its receptor on the oocyte may activate different signaling 
pathways.  Among these, cellular response occurs through the 
phosphatidylinositol 3 kinase
Many studies have attempted to disrupt functionality of the Kit 
system by using an antibody to block the binding of cKit to its ligand.  
 (PI3K) pathway, the pathway thought to 
control primordial follicle activation (John et al., 2009).  This is supported 
with the discovery that KL treatments of mouse and rat oocyte cultures 
results in phosphorylation of PI3K pathway components protein kinase B 
(PKB) and its substrate, forkhead homolog rhabdomyosarcoma-like 1 
(FKHRL1).  This phosphorylation activates PKB, involved in cell 
proliferation, and suppresses FKHRL1, involved in apoptosis.  Expression 
of these PI3K components following KL treatment supports the suggestion 
that the Kit system regulates follicle development and affects secretion of 
oocyte factors that regulate the primordial to primary follicle transition 
(Reddy et al., 2005).  Recent in vivo work using mice with a mutation 
preventing cKit signaling via PI3K provided evidence that cKit is not a 
required factor, since primordial follicle activation still occurred in these 
mice.  Nevertheless, abnormalities in these mice, such as primordial follicle 
depletion, support the importance of cKit in promoting survival of 
primordial follicles (John et al., 2009). 
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Addition of an antibody to cKit to mouse preantral follicle cultures showed 
that antrum formation was severely affected and oocyte death occurred after 
six days, an effect found to be independent of somatic cell survival (Reynaud 
et al., 2000).  Similarly, blocking cKit with an antibody significantly increases 
follicular atresia in human ovarian cultures (Carlsson et al., 2006), while in 
cattle, it was able to completely block KL-stimulated follicle activation 
(Muruvi and Fortune, 2009).  A different approach to inhibit cKit activity 
was used to investigate the role of cKit signaling in FSH-stimulated oocyte 
growth in the mouse.  An inhibitor of cKit tyrosine kinase activity (Gleevec, 
specific to just three of the known tyrosine kinases), was used in granulosa 
cell cultures in the presence of FSH plus oocytes.  This attenuated FSH-
induced inhibition of BMP15, suggesting a cKit-mediated action of FSH.  
However, the study also showed that FSH treatments had no effect on cKit 
mRNA (Thomas et al., 2005).   
A few factors that have a role in the regulation of cKit have been 
identified.  In one study, mRNA for cKit was increased from cultured 
bovine COCs after treatment with FGF7.  Additional experiments showed 
that the stimulatory effect of FGF7 on oocyte growth was inhibited by the 
addition of an antibody to cKit (Cho et al., 2008).  Microarray analysis of rat 
whole ovaries cultured in the presence of AMH indicated suppression of 
cKit mRNA by AMH (Nilsson et al., 2007).  Since AMH is known to inhibit 
the primordial-to-primary follicle transition (Durlinger et al., 1999; Durlinger 
et al., 2002), this relationship may be important in the regulation of 
folliculogenesis. 
It has been well documented that the Kit system plays an important 
role in mammalian reproduction.  The numerous interactions that KL and 
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cKit have with other factors can be autocrine, paracrine or endocrine in 
nature, and in many cases, it is still not well understood whether effects seen 
are direct or indirect.  It is important to study the Kit system in the 
reproduction of other non-mammalian vertebrates, such as the chicken.  The 
unique arrangement of the ovarian follicle hierarchy in the domestic hen 
makes it a fine model to study factors involved in folliculogenesis. 
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Table 1.1 Factors Regulating KL Expression in Granulosa Cells 
 
Factor Endogenous 
Source 
Effect Species 
FSH Anterior pituitary ↑ Mouse (Joyce et al., 1999), 
Cow (Parrott and Skinner, 
1998) 
LH/hCG Anterior pituitary      ↓ Cow (Parrott and Skinner, 
1998), Mouse (Ye et al., 
2009), Rat (Ismail et al., 
1996) 
HB-EGF Oocyte ↓ Chicken (Wang et al., 2007) 
BMP15 Oocyte      ↓ Rat (Otsuka and Shimasaki, 
2002), Mouse (Joyce et al., 
2000; Thomas et al., 2005) 
GDF9 Oocyte      ↓ Mouse (Joyce et al., 2000; 
Elvin et al., 1999) 
bFGF Oocyte ↑ Rat (Nilsson and Skinner, 
2004) 
LIF Granulosa or 
oocyte 
↑ Rat (Nilsson et al., 2002) 
AMH Granulosa      ↓ Rat (Nilsson et al., 2005) 
FGF7 Theca & 
granulosa 
↑ Cow (Cho et al., 2008) 
Testosterone Theca & 
granulosa 
↑ Mouse (Joyce et al., 1999) 
KGF Theca ↑ Cow (Parrott and Skinner,  
1998) 
HGF Theca ↑ Cow (Parrott and Skinner,  
1998) 
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Table 1.2 Functions of KL in the Ovary 
 
Factor 
Regulated 
Endogenous 
Source 
Effect Species 
BMP15 Oocyte      ↓ Rat (Otsuka and 
Shimasaki, 2002; 
Thomas et al., 2005) 
bFGF Oocyte ↑ Rat (Jin et al., 2005) 
Aromatase Ooctye ↑ Rat (Jin et al., 2005) 
SF-1 All ovarian cells ↑ Rat (Jin et al., 2005) 
StAR All ovarian cells ↑ Rat (Jin et al., 2005) 
FSHR Granulosa      ↓ Rat (Jin et al., 2005) 
Testosterone Theca ↑ Mouse (Reynaud et al., 
2000) 
KGF Theca ↑ Cow (Parrott and 
Skinner, 1998) 
HGF Theca ↑ Cow(Parrott and 
Skinner, 1998) 
Proliferation Theca, granulosa ↑ Mouse (Reynaud et al., 
2000), Cow (Parrott and 
Skinner, 1997) 
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Figure 1.1 Interactions of KL with other intraovarian factors in  
the mammalian ovary 
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1.2 ACTIONS OF ANTI-MÜLLERIAN HORMONE IN THE 
OVARY 
Anti-Müllerian hormone (AMH, also known as Müllerian inhibiting 
substance, MIS), named for its role in regressing the Müllerian duct system 
in male mammals, has the same function in male birds, in addition to 
regressing the right Müllerian duct in female birds (Tran and Josso, 1977).  
Estrogen produced by the left ovary of birds protects the left Müllerian duct 
from regression, discovered by in vivo treatments with DES that prevented 
apoptotic cell death of the right Müllerian duct (Teng, 2000; Teng, 2001).   
Actions of AMH in mammalian reproduction 
Although no receptors for AMH have been identified thus far in the 
chicken, two receptors have been identified in rodents (di Clemente et al., 
1994).  As a member of the TGFβ superfamily, AMH signals through type I, 
type II receptors, utilizing the Smad second messenger system.  In this 
system, once a ligand binds its type II receptor, the type I receptor is 
additionally recruited to bind to this ligand-receptor complex.  Activation of 
these two transmembrane serine-threonine kinase receptors results in 
subsequent downstream signaling via Smad proteins (Massague and Chen, 
2000).  AMH signal transduction was shown to be mediated through Smad1 
and Smad5, type I BMP downstream signaling molecules, but not mediated 
by Smad2, a TGFβ-like signaling Smad (Visser et al., 2001).  Expression of 
the AMH type II receptor is found in embryonic Müllerian duct 
mesenchymal cells and gonads as well as postnatal rodent granulosa cells 
(Baarends et al., 1994; Baarends et al., 1995) and rat preantral and antral theca 
cells (Ingraham et al., 2000).  The type I receptor (ALK2) is also expressed in 
fetal and adult mouse ovaries (Visser et al., 2001).   
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Expression of AMH mRNA or protein is not seen in mouse 
primordial follicles, oocytes or theca, and can be first seen in granulosa cells 
of primary follicles (Ueno et al., 1989; Baarends et al., 1995; Durlinger et al., 
2002).  AMH is highest in preantral and small antral follicles, with greater 
expression in granulosa cells surrounding the oocyte and antrum, as 
compared to the mural granulosa cells, possibly reflecting functional 
differences between the cells (Ueno et al., 1989; Baarends et al., 1995; 
Durlinger et al., 2002).   
AMH knock-out studies indicate the importance of AMH in normal 
ovarian function.  Female knock-out mice appear normal and are fertile, 
which may indicate some functional redundancies with other factors such as 
inhibin and activin (Behringer et al., 1994).  Further study of ovaries from 
these null mice demonstrated that AMH is an inhibitor of follicular 
activation.  The number of small, growing follicles was found to be greatly 
increased, leading to a depletion of primordial follicles in the ovaries of older 
mice (Durlinger et al., 1999).  This function was confirmed by in vitro studies 
showing that murine ovaries cultured with AMH had 40% fewer growing 
follicles and lower α-inhibin mRNA expression (Durlinger et al., 2002).   
AMH has the ability to decrease FSH sensitivity, with a proposed 
inverse pattern of follicular expression between FSHR and AMH, a 
relationship which may regulate orderly follicle selection (Visser and 
Themmen, 2005).  By culturing follicles, it was discovered that preantral 
follicle growth stimulated by FSH treatment was reduced with addition of 
AMH (Durlinger et al., 2001).  Furthermore, AMH-deficient mice given 
injections of FSH had higher numbers of growing follicles when compared 
to wild-type mice, demonstrating the inhibitory regulation by AMH on 
16 
 
follicle recruitment (Durlinger et al., 2001).  Other examples of AMH 
attenuation of FSH actions were found in cultured rat granulosa cells treated 
with FSH ±AMH or cAMP ±AMH.  FSH and cAMP both stimulated 
aromatase activity that was blocked with the addition of AMH.  AMH also 
decreased FSH-stimulated granulosa cell LHR.  These results are interesting 
because LHR and aromatase are two markers of granulosa cell 
differentiation (di Clemente et al., 1994).  Furthermore, microarray analysis of 
AMH-treated rat ovaries showed that AMH downregulated the TGFβ 
pathway which signals for processes including cell differentiation, 
angiogenesis and cell cycle regulation (Nilsson et al., 2007). This study also 
showed that the stimulatory actions of KL, bFGF and KGF on the 
transition from primordial to primary follicles in ovary cultures were 
attenuated by addition of AMH to culture treatments (Nilsson et al., 2007).   
Further evidence that AMH suppresses follicle activation was 
demonstrated in the cow.  In this study, pieces of bovine ovarian cortex 
filled with primordial follicles were grafted beneath the chorioallantoic 
membranes (CAM) of chick embryos, an approach used because ovaries of 
large mammals cannot be cultured intact.  This experiment showed an 
inhibition of follicle activation, presumed to be due to the high levels of 
AMH produced by chick embryonic gonads (Cushman et al., 2002).  An 
additional study repeated this experiment, instead using CAM of 
gonadectomized chick embryos, and found that follicle activation ensued 
(Gigli et al., 05).  This experiment was also done using mouse ovaries, and 
showed that follicle activation in wild-type whole ovaries was inhibited, and 
yet no inhibition occurred when cultured in vitro or when using CAM-grafted 
ovaries of AMH type II receptor knock-out mice (Gigli et al., 05).   
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Studies in human reproduction have linked AMH to various forms of 
ovarian dysfunction.  Correlations are seen between low serum AMH and 
premature ovarian failure (POF) (Meduri et al., 2007) in addition to high 
levels of serum AMH seen in women with polycystic ovary syndrome 
(PCOS) (Cook et al., 2002).  AMH is currently believed to be the best known 
marker of ovarian reserve; AMH decreases with age, reflecting declines in 
the oocyte and follicle pool (Van Rooij et al., 2004).  AMH is also useful in 
predicting outcomes of ovarian response to assisted reproductive 
technology, specifically gonadotropin stimulation (Seifer et al., 2002). 
AMH in the domestic hen ovary 
The sequence of chicken AMH is 52% similar to mammalian AMH in 
the biologically active C-terminal region.  In the female embryo, expression 
of AMH in the developing left ovary was found to gradually increase to its 
highest level at day 14 then decline to close to baseline by the day before 
hatching (Teng et al., 1987).  In the adult hen, AMH mRNA expression in 
granulosa cells is highest in small, growing follicles and decreases with 
follicle development (Johnson et al., 2008).   
Interestingly, when comparing two breeds of hens with different 
ovulation rates, high levels of AMH expression were correlated with 
impaired follicle selection (Johnson et al., 2009).  AMH was found to be 
higher in hens on a diet of free feeding than those on restricted feeding.  
When allowed to eat ad libitum these hens become very fat, display excessive 
follicle development, and frequently experience erratic ovulations.  Further 
experiments determined that AMH was not regulated by glucose or insulin, 
factors related to metabolic state (Johnson et al., 2009).  The finding that 
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follicle development is not optimal when AMH is high is similar to the 
relationship found in women with PCOS (Cook et al., 2002).   
Culture of 6-8 mm granulosa cells with various concentrations of 
estradiol and progesterone showed that neither steroid was able to influence 
AMH mRNA expression in the hen.  In contrast, cultures treated with 
oocyte-conditioned medium (OCM) revealed decreased AMH mRNA 
expression.  This suppression by one or more oocyte-derived factors was 
eliminated when the OCM was heat-treated, but was not blocked by the 
addition of an antibody to GDF9 (Johnson et al., 2008).  With regard to 
AMH actions in the hen ovary, not much is known.  This is, in large part, 
due to the fact that mammalian AMH preparations are biologically inactive 
in the hen.  One experiment treated granulosa cell cultures with bioactive 
AMH, shown to be present in testis-conditioned medium (TCM) by western 
blot analysis.  Through a paracrine or autocrine mechanism, AMH induced 
cell proliferation that was blocked when the TCM was preincubated with an 
antibody to AMH (Johnson et al., 2009).  As knowledge of AMH regulation 
and function in the hen ovary is limited to these few studies, there is a need 
for further investigation of its actions and regulation in an oviparous species.   
 
1.3 FUNCTION AND REGULATION OF OOCYTE FACTORS IN 
THE HEN 
Folliculogenesis is a dynamic and precise developmental process in all 
vertebrates.  While much is known about the numerous factors that play a 
role in follicle maturation, there are still vast amounts of research to be done 
on the interactions of growth factors that come from the follicle, the 
functional unit of the ovary.  Much of the focus has been on the granulosa 
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and theca cell layers, with few studies on paracrine or autocrine factors 
expressed by the oocyte.  Expanding this knowledge should be a vital goal in 
gaining a better understanding of ovarian physiology.  In particular, the 
unique hierarchal arrangement of follicles in the hen ovary makes it an ideal 
model to study these interactions relative to the process of folliculogenesis.  
Germinal Disc 
Communication between the oocyte and its surrounding cells is 
important for all systems of reproduction.  The avian germinal disc (GD) is a 
tiny white structure on the surface of the oocyte that contains the nucleus 
and 99% of the cell’s organelles, including the DNA and mitochondria.  The 
germinal disc and its overlying granulosa cells comprise the germinal disc 
region (GD), said to be the growth center of the follicle (Tischkau et al., 
1997).  The GD is the structural and functional equivalent of the mammalian 
oocyte, but in reality the chicken oocyte includes the yolk.  In a preovulatory 
follicle, granulosa cells are defined by their proximity to the GD: GD 
granulosa cells are found covering the germinal disc and nonGD granulosa 
cells are on the distal side of the follicle.  These subsets have different 
properties; GD granulosa cells are very proliferative and incorporate more 
[3
EGF 
H] thymidine, a measure of mitosis.  NonGD granulosa cells are more 
differentiated and produce greater amounts of progesterone (Tischkau et al., 
1997; Yao and Bahr, 2001b).   
It was shown that destruction of the preovulatory GD resulted in 
apoptosis and the absence of ovulation, which means the GD produces one 
or more growth factors required to sustain follicle development (Yoshimura 
et al., 1994).  One paracrine regulator of preovulatory granulosa cells is 
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epidermal growth factor (EGF), found in GD-region-conditioned media 
(Yao and Bahr, 2001b).  Culture treatments with this media (plus normal 
rabbit serum) increased granulosa cell proliferation compared to control 
treatments (lacking serum), an effect that was blocked by addition of an 
EGF antibody (Yao and Bahr, 2001b).  This finding is supported by other 
work in the chicken showing that EGF stimulates proliferation, inhibits 
apoptosis, and decreases progesterone production by granulosa cells 
(Volentine et al., 1998) and that EGF decreases LHR in preovulatory GD 
granulosa cells (Yao and Bahr, 2001a). 
GDF9 
Two related TGFβ superfamily members derived from the oocyte are 
bone morphogenic protein 15 (BMP15) and growth differentiation factor 9 
(GDF9).  Biological forms of these proteins share interesting similarities 
such as their lack of the cystine involved in dimer formation in most other 
members of the superfamily.  However, because both are produced in the 
oocyte, they may form biologically active homodimers or heterodimers 
(Juengel et al., 2004).  While both factors are known to signal through the 
type II receptor BMPRII, they signal through different type I receptors, 
ALK6 for BMP15; ALK5 for GDF9 (Moore et al., 2003; Mazerbourg et al., 
2004).   
In the hen ovary, GDF9 exhibits highest expression in the oocyte, but 
was also shown to be in granulosa cell mRNA at low levels in follicles up to 
8 mm, with no difference between GD and nonGD granulosa cells.  
Furthermore, immunocytochemistry showed staining predominantly in the 
oocyte, highest in the periphery, with limited positive staining in the 
granulosa cells (Johnson et al., 2005b).  GDF9 is more likely to be involved 
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in follicle differentiation than in early embryo development, as mRNA 
expression during early embryogenesis was shown to decrease to very low 
levels following ovulation (Elis et al., 2007).   
Chicken GDF9 was shown to be present in oocyte-conditioned media 
(OCM) via western blot analysis (Johnson et al., 2005b).  Treatment of 
granulosa cells from 3-8 mm follicles with OCM resulted in increased 
granulosa cell proliferation.  This effect is attributed to GDF9, because pre-
treatment of OCM with GDF9 antibody returned proliferation levels to 
baseline (Johnson et al., 2005b).  Although we have limited information 
about the function of GDF9 in the hen, mammalian studies have outlined its 
importance in folliculogenesis.  The GDF9 knock-out mouse model exhibits 
disrupted follicle development with no progression past the primary stage 
(Dong et al., 1996).  In mammals, GDF9 is also found to regulate steroid 
production by the theca and granulosa cell layers (Elvin et al., 2000; 
Solovyeva et al., 2000). 
BMP15 
In chickens, BMP15 mRNA was shown via in situ hybridization to be 
highly expressed in oocytes from follicles ranging from 50 µm to 6 mm in 
size.  This finding was supported by high expression of BMP15 in the GD 
of preovulatory follicles via real-time RT-PCR; additionally, low levels of 
BMP15 mRNA were observed in granulosa cells of these follicles (Elis et al., 
2007).  Treatment of chicken granulosa cells with rhBMP15 (72% identity 
with chicken) affected steroid production and signaling in a number of ways.  
BMP15 was found to inhibit gonadotropin-stimulated granulosa cell 
progesterone production, an effect correlated with BMP15 suppression of 
StAR protein.  However it had no effect on the steroidogenesis enzymes 3β-
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HSD and P450SCC
Study of BMP15 actions in the rat ovary suggested functions similar 
and different to those described in the hen ovary.  Rat granulosa cells, the 
target cells of BMP15 signaling, were treated with BMP15, which increased 
cell proliferation (Otsuka et al., 2000), an effect not seen in the hen (Elis et 
al., 2007).  Furthermore, BMP15 was shown to decrease FSH-stimulated 
progesterone production in both the rat (Otsuka et al., 2000) and the hen 
(Elis et al., 2007), but did not affect FSH-stimulated estradiol production by 
rat granulosa cells (Otsuka et al., 2000). 
.  BMP15 was also able to increase Smad1 
phosphorylation, activating a signaling pathway in granulosa cells (Elis et al., 
2007).  Various studies in mammals have shown the importance of BMP15 
in reproduction may be species specific.  For example, BMP15 knock-out 
mice are fertile (Yan et al., 2001), yet loss of function in humans results in 
ovarian failure (Di Pasquale et al., 2004).  The loss of BMP15 function in 
sheep yields non-linear effects: partial loss increases ovulation rates, while 
complete loss renders sheep infertile (Juengel et al., 2002; Hanrahan et al., 
2004).   
HB-EGF 
Another oocyte-derived factor that has been studied in the chicken is 
HB-EGF, which has low expression in the embryo and high expression in 
immature and mature ovaries (highest in 10 week old chickens).  In a 3 mm 
follicle, HB-EGF was found to be highly expressed in the oocyte and weakly 
expressed in granulosa, while its receptor, EGFR, has strong granulosa cell 
expression.  Treatment with various doses of HB-EGF greatly increased 
granulosa cell proliferation and downregulated KL expression in follicles of 
all sizes, as discussed previously (Wang et al., 2007).  
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1.4 REPRODUCTIVE BIOLOGY OF THE DOMESTIC HEN 
Reproductive cycle 
A major anatomical difference between mammals and birds is the 
solitary existence of the left ovary and oviduct in birds, compared to two of 
each found in mammals.  As embryos, birds begin with both ovaries and 
oviducts, but by day four there is a disproportionate balance of primordial 
germ cells that advances development of the left ovary alone.  As previously 
discussed, regression of the right oviduct begins by day ten (Tran and 
Josso, 1977).   
In the hen’s 24-28 hour ovulation-oviposition cycle, a single follicle is 
selected for ovulation.  Ovulation is the release of an ovum from a ruptured 
follicle, which then travels through the reproductive tract, gaining layers of 
membrane, albumen and shell.  The process of generating a fully formed egg 
takes 25-26 hours and culminates in oviposition, the laying of an egg (Fraps 
and Hammond, 1955).  The typical laying pattern consists of several days of 
consecutive ovulations known as a sequence, followed by a pause day 
(Etches, 1996).   
Hen ovaries exhibit a defined follicular hierarchy (Illustration 1.1) 
that permits these successive ovulations, where the follicles range in size 
representative of the order in which they are selected to ovulate.  There are 
between five and eight large yellow, yolk-filled follicles (LYF), with F1 being 
the largest and therefore next to ovulate, followed by F2, and so on (Gilbert 
et al., 1983).  Hens have a resting primordial pool from which this 
preovulatory hierarchy originates.  Initially, primary oocytes are enclosed by 
a vitelline membrane.  With the addition of granulosa cells that form the  
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Illustration 1.1 Photograph of the hen ovary 
Photograph depicts the unique anatomy of the hen ovary, emphasizing the 
highly regulated hierarchy of preovulatory follicles. 
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perivitelline membrane (similar to the mammalian zona pellucida), a small 
white follicle is formed (SWF, <2 mm diameter) (Gilbert et al., 1983).  As a 
SWF develops, a theca layer, produced from mesenchymal cells, is formed.  
The basal lamina separates the theca and granulosa layers (Johnson et al., 
2007).  Theca differentiation into interna and externa, along with 
accumulation of white yolk (less lipid content than yellow) classifies the large 
white follicles (LWF, 2-4 mm diameter).  As yellow yolk is taken up by the 
growing oocyte, the small yellow follicles develop, (SYF, 6-12 mm diameter) 
a stage approximately 2-3 weeks from ovulation.  At this point, the theca 
layer starts to become vascularized and innervated (Johnson et al., 2007).  
These SYF make up the pool of prehierarchal follicles, characterized by slow 
growth, from which they are recruited to enter the preovulatory hierarchy 
(Etches, 1996).  Once a follicle is selected into the hierarchy it is destined to 
ovulate (Gilbert et al., 1983).  Following this selection, follicles grow very 
quickly up to 40 mm (Johnson et al., 2007).  This vast increase in size is due 
to receptor-mediated uptake of increasing amounts of yellow yolk, a protein 
mass made by the liver in response to estrogen that circulates in the blood 
(Barber et al., 1991).  Avian follicles lack the follicular fluid and antrum seen 
in the mammalian follicle and contain the highly specialized germinal disk 
region (Etches, 1996).   
Steroid Production 
Accompanying the increase in size with follicle maturation, various 
other changes occur in the cell layers surrounding the oocyte.  Steroid 
production in preovulatory follicles occurs via the Δ4 pathway, while the Δ5 
pathway is highly utilized by prehierarchal follicles and stromal tissue 
(Johnson, 1996).  Estradiol, synthesized by theca externa cells with 
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aromatase activity (Nitta et al., 1991), is the main steroid produced by the 
small white follicles (Robinson and Etches, 1986).  The granulosa cells from 
these same follicles are not steroidogenic due to their lack of P450SCC
Immediately after selection (9-12 mm follicles), mRNA for the 
enzyme P450
 
enzyme activity (Tilly et al., 1991).   
SCC
Steroid production is an important factor in the timing of ovulation.  
Levels of estradiol, believed to prepare the hypothalamus for positive 
feedback of progesterone, peak 4-6 hours before ovulation.  During these 
hours before ovulation, the F1 follicle is the major source of progesterone.  
Rising plasma concentrations of progesterone stimulate GnRH secretion 
which acts on the pituitary to trigger secretion of LH.  Acting through its 
receptor, this LH further stimulates progesterone production primarily by 
granulosa cells of F1.  This positive feedback loop generates the 
preovulatory surge (Johnson and van Tienhoven, 1980; Johnson, 1996; 
Etches and Cunningham, 1976).  In contrast to the interactions of LH and 
progesterone seen in the hen, mammalian dominant follicles produce high 
levels of estradiol, thought to inhibit FSH secretion in order to suppress 
growth of subordinate follicles (Fortune, 2004).  This regulation of follicle 
 increases, and the granulosa cells become steroidogenically 
competent, primarily producing progesterone (Johnson, 1996).  As 
progesterone production increases to maximal levels during preovulatory 
follicle growth from F5 (120 hours before ovulation) to F1, estradiol 
simultaneously decreases.  Testosterone, synthesized by granulosa and theca, 
increases from F5-F2, then decreases in F1 (Bahr et al., 1983).  Similarly, 
androstenedione, a precursor of androgens and estrogens, is lowest in F1 
(Etches and Duke, 1984). 
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development also occurs in the avian hierarchy, acting primarily through 
progesterone and inhibin (Johnson, 1996), which will be discussed later in 
greater detail. 
Gonadotropin Involvement 
Follicular development is mediated by the gonadotropins, luteinizing 
hormone (LH) and follicle stimulating hormone (FSH).  The primary 
functions of FSH are in follicle development and the LH surge induces 
ovulation.  In order to achieve these objectives, LH and FSH act on the 
ovary following their release from the anterior pituitary.  An important 
aspect of their activity is seen in their regulation of steroid synthesis, through 
actions on P450SCC
Other work has examined gonadotropin effects on P450
 or StAR, both necessary for steroid production.  In one 
study, western blot analysis showed increased granulosa StAR protein 
following a four hour incubation with FSH in all follicle sizes (Woods and 
Johnson, 2005).  Another study indicated that LH was also able to increase 
StAR protein expression in preovulatory follicle granulosa cells, through 
signaling via the PKC pathway.  Interestingly, activation of this pathway in 
undifferentiated granulosa cells has been shown to suppress FSH-induced 
StAR protein levels (Woods et al., 2007).   
SCC enzyme 
activity.  In follicles following selection (9-12 mm), four hour incubations 
with FSH and VIP were found to initiate P450SCC enzyme activity, resulting 
in high levels of progesterone synthesis.  In contrast, this effect was not 
found in the F1 follicle after treating with FSH or VIP (Johnson, 1993).  
Although LHR are detectable in 9-12 mm follicles, they were found to be 
insufficient for LH-induced progesterone production.  Again, granulosa 
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from the F1 follicle exhibited a different response, showing elevated 
progesterone synthesis following incubation with LH (Johnson, 1993). 
The increase in progesterone production in preovulatory follicles goes 
along with the finding that granulosa LHR mRNA drastically increases at the 
F3 follicle stage.  Theca cells also express LHR in these follicles, decreasing 
at F1, but LHR mRNA levels change very little in comparison to the change 
seen in granulosa cells (Johnson, 1996).  As this LH responsiveness increases 
with follicle maturation, there is a parallel decrease in FSH responsiveness, in 
the form of decreased FSHR (Johnson, 1993).  Expression of FSHR mRNA, 
lowest in the F1, exhibits high expression in 1-2 and 3-5 mm follicle stages.  
FSHR reaches its highest levels in 6-8 and 9-12 mm follicles, coinciding with 
follicle selection.  One follicle from the 6-8 mm prehierarchal pool was 
shown to have much higher FSHR mRNA expression than the rest and 
therefore presumed to be the next follicle selected (Woods and Johnson, 
2005). 
Other important factors 
As follicles mature they accumulate yolk, taken up by the oocyte as 
mentioned above (Barber et al., 1991).  In smaller follicles, tight junctions in 
granulosa cells prevent yolk precursors (VLDL and vitellogenin) from 
reaching receptors on the oocyte.  Protein expression of occludin, necessary 
for these tight junctions, decreases greatly with follicular maturation from 
SWF to SYF, and is undetectable in isolated F1 granulosa.  Granulosa 
occludin expression was shown to increase by culturing with activin A 
±FSH, and decrease with TGFα ±activin A (Schuster et al., 2004). 
The inhibin/activin family of hormones is also known to have an 
important role in the regulation of folliculogenesis.  Corresponding with 
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follicle maturation, changes in what has been described as “activin tone” 
occur concomitantly with inverse changes in “inhibin tone.”  Therefore their 
actions differ with different stages of development (Lovell et al., 2003).  
Protein and mRNA expression of the three inhibin subunits (α, βA, βB) that 
homo- and hetero-dimerize to form the members of the inhibin/activin 
family vary with follicle size in the chicken.  The majority of circulating 
inhibin A (αβA subunits) is produced by granulosa cells of hierarchal follicles 
F1-F4 (Wang and Johnson, 1993; Chen and Johnson, 1996), while 6-10 mm 
small yellow follicles are the source of inhibin B (αβB
Inhibin and activin were initially discovered, and named, for their 
opposing abilities in endocrine regulation of FSH.  Inhibin reduces pituitary 
secretion of FSH while activin stimulates secretion.  In addition to this 
important role, they provide paracrine regulation in follicle selection and 
development (reviewed in Mather et al., 1997; Findlay, 1993).  A recent study 
using a neonatal (cancer-free) inhibin knock-out mouse (Myers et al., 2009) 
revealed that the loss of inhibin disrupted early follicle development, 
possibly due to increased activin signaling.  Ovaries from these mice 
exhibited unusually small oocytes along with an obvious increase in ovary 
size.  These effects could also be due to the altered gene expression that was 
), maximal in 6-8 mm, 
suggesting its role in follicle selection (Hecht, 2000).  Large white follicles 
show low levels of inhibin protein expression for all subunits (Johnson, 
2005a).  Follistatin is a soluble binding protein that can bind inhibins and 
activins through the β subunit, capable of binding activin with higher affinity 
due to its two β subunits.  Follistatin mRNA and protein expression is found 
in theca and granulosa and is more highly expressed in prehierarchal than in 
hierarchal follicles (Lovell et al., 2003; Davis and Johnson, 1998).   
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discovered: increased cyclin D2 and GDF9; decreased KL, AMH and 
BMP15 (Myers et al., 2009).   
Regulation of inhibin and activin in the hen has also been studied 
extensively.  These results include increased expression of α and βA mRNA 
due to FSH and LH (Davis et al., 1999; Davis et al., 2001; Safi et al., 2003), 
IGF1 (Safi et al., 2003), and BMP6 (Al-Musawi et al., 2007).  BMP6 
additionally stimulated βA mRNA expression (Al-Musawi et al., 2007), while 
FSH elevated follistatin mRNA, but inhibited βB mRNA expression, 
although this result varied with follicle size (Davis et al., 2001).  Following 
treatment of granulosa cell cultures with estradiol, mRNA expression of βA, 
βB
The tightly regulated process of folliculogenesis ultimately culminates 
in the ovulation of a follicle.  Factors important for successful ovulation 
include steroids and gonadotropins, already discussed, as well as the 
plasminogen activators (PA), present in both follicular fluid and the follicle 
wall.  The two types of PAs identified in the chicken, urokinase and tissue 
type, assist in degrading the follicle wall by converting plasminogen to the 
active plasmin at the time of ovulation (Beers, 1975; Johnson et al., 1997).  In 
the hen, F1 granulosa cell-derived PA activity is regulated by several factors, 
often in ways not seen in mammals.  PA activity was found to be inhibited 
by testosterone and progesterone treatments and stimulated by EGF, TGFα, 
TGFβ, PGE
 and follistatin was elevated (Davis et al., 2000).  Altogether, these findings 
tell us that inhibin and activin are subject to endocrine, paracrine and 
autocrine regulation, evidence which strongly supports their importance in 
hen reproduction.  
1 and PGE2 (Tilly and Johnson, 1987; Tilly and Johnson, 1990a; 
Tilly and Johnson, 1990b; Lafrance et al., 1993a; Lafrance et al., 1993b).  PA 
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is also produced at higher levels by hierarchal follicle GD granulosa (high 
throughout) than nonGD, which decreased significantly in a stage-
dependent manner (Tischkau et al., 1997). 
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CHAPTER 2 
EXPRESSION AND REGULATION OF KIT LIGAND IN THE 
OVARY OF THE HEN 
 
2.1 INTRODUCTION 
Functionality of the Kit system, composed of Kit ligand (KL) and its 
cognate tyrosine kinase receptor, cKit, has been shown to be essential in a 
variety of tissues and processes (Hutt et al., 2006).  KL is a cytokine that has 
two primary isoforms (soluble and membrane-spanning), that initiates its 
biological activity by binding to the cKit receptor in its extracellular domain 
(Lemmon et al., 1997).  There is also evidence of a soluble form of cKit that 
consists of part of the extracellular domain.  This is proposed to bind KL 
with high affinity and thus could prevent binding of KL with the membrane-
associated cKit (Tanikawa et al., 1998).  In the current study, we postulate 
that a soluble cKit is available in our bioactive media and has the ability to 
exert effects by binding KL.  In the chicken, the Kit system has been 
implicated in proliferation of normal haemopoeitic cells (Hayman et al., 
1993), proliferation and differentiation of neural crest-derived melanocytes 
(Lahav et al., 1994), differentiation and functional activation of osteoclasts 
(Van’t Hof et al., 1997), and assisting in the survival of dorsal root ganglia 
neurons in vitro (Carnahan et al., 1994).  There has been limited examination 
of the KL/cKit system in the ovary of chickens. 
In the chicken, the soluble and longer isoform of KL is a 287 amino 
acid polypeptide shown to be present in many tissues (Zhou et al., 1993).  
Although KL expression throughout follicle development in the chicken 
ovary is currently unreported, four isoforms of one chicken KL gene have 
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been identified and cloned: KL-1, KL-2, KL-3 and KL-4.  Of these, KL-1 
was reported to be primarily expressed in the ovary (Wang et al., 2007). 
The ovarian expression pattern of KL mRNA and protein has been 
well studied in mammals.  In the mouse, KL protein and mRNA was 
detected in follicle granulosa cells at all stages of development, with low 
expression found in primordial follicles and then increasing with follicle 
growth to the highest levels in preantral follicles.  KL expression is decreased 
to low levels in cumulus cells of antral follicles, while remaining high in 
mural granulosa cells (Motro and Bernstein, 1993).  In goats, KL protein and 
mRNA were expressed in granulosa cells at all stages of development with 
highest expression found in secondary follicles (Celestino et al., 2010).  
Similarly, granulosa cell KL mRNA expression has been shown in the rat 
(Ismail et al., 1996), sheep, (Tisdall et al., 1999) human (Hoyer et al., 2005) and 
pig (Brankin et al., 2004).   
In mammalian reproduction, regulation of KL occurs through 
endocrine, paracrine, and autocrine signaling.  Treatment with FSH 
significantly increased KL mRNA expression in bovine (Parrott and Skinner, 
1998) and murine (Joyce et al., 1999) granulosa cell cultures.  Increased KL 
mRNA expression in granulosa cultures was also found after testosterone 
treatment (Joyce et al., 1999).  Other research found no effect on soluble KL 
mRNA with FSH treatments in the mouse and increased membrane-bound 
KL mRNA with low (but not high) FSH treatment (Thomas et al., 2005).  In 
contrast, in human granulosa-luteal cell cultures, FSH treatment was shown 
to significantly decrease KL mRNA expression (Laitinen et al., 1995). 
With respect to paracrine regulation of KL, oocyte-derived BMP15 
treatment of granulosa cells co-cultured with oocytes significantly increased 
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KL mRNA in rats (Otsuka and Shimasaki, 2002) and in mice (Thomas et al., 
2005).  Addition of partly grown oocytes to mouse granulosa cell culture also 
promotes KL mRNA expression, an effect thought to be attributed to the 
presence of BMP15 in the oocytes (Joyce et al., 1999; Joyce et al., 2000).  
Although granulosa cell-derived AMH had no direct effect on KL gene 
expression, the stimulatory effects of KL on rat primordial follicle 
development were inhibited by AMH added to whole ovary culture.  This 
suggests that AMH could act in an autocrine manner to regulate KL activity 
(Nilsson et al., 2007). 
A single study that investigated autocrine regulation of KL in the 
chicken ovary revealed that heparin binding EGF-like growth factor (HB-
EGF) treatment resulted in a dose-dependent decrease of granulosa cell KL 
mRNA.  This inhibitory effect was seen in granulosa cells from 3 mm, 6 
mm, F4+5, and F1 follicles (Wang et al., 2007).  
The 960 amino acid sequence of chicken cKit was detected in many 
organs including the brain, bursa, heart, kidney, spleen, thymus, ovary, and 
testis (Sasaki et al., 1993).  Whereas the ovarian expression pattern of cKit in 
the chicken has not been established, cKit protein and mRNA expression was 
shown in oocytes of mice (Motro and Bernstein, 1993; Horie et al., 1991), 
sheep (Tisdall et al., 1999), goats (Silva et al., 2006), pigs (Brankin et al., 2004), 
and humans (Horie et al., 1991; Carlsson et al., 2006).  Expression was also 
found in theca of mice (Motro and Bernstein, 1993), pigs (Brankin et al., 2004), 
and cattle (Parrott and Skinner, 1997).  As previously stated, a soluble form of 
cKit has also been found in human follicular fluid (Tanikawa et al., 1998).   
The cKit receptor must bind to its ligand to become biologically 
activated; therefore functionality of cKit (membrane-bound) is dependent on 
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interactions with KL.  With respect to reproduction, binding of granulosa 
cell KL to its receptor on the oocyte may activate different signaling 
pathways.  Among these, cellular response occurs through the 
phosphatidylinositol 3 kinase
The ovary of the laying hen contains five to eight large yolk-filled 
follicles that are arranged in a hierarchy according to size representative of 
the order in which they are selected to ovulate, with F1 being largest and 
therefore next to ovulate, followed by F2 (Gilbert et al., 1983).  Development 
of these follicles is well-regulated, with a 24-26 hour period between 
ovulations.  With each ovulation the follicles progress through the hierarchy 
and an additional follicle is recruited from the pool of nonhierarchal follicles 
that consists of small yellow follicles (5-10 mm diameter) and small white 
follicles (<5 mm diameter) (Gilbert et al., 1983).  A single follicle per day is 
selected from the pool of 6-8 mm follicles to enter the preovulatory 
hierarchy, making this group very interesting to study.  The present studies 
were designed to characterize KL in the ovary of the hen with a goal to 
understand the role of the Kit system in follicle development in the hen.  
These include study of the developmental pattern of KL expression, the 
effects of oocyte factors, steroids and FSH on KL expression, and functions 
of the Kit system in steroid regulation.  Investigation of FSH and oocyte 
factors such as GDF9 and BMP15 is based on previous reports that these 
effect KL expression in the mouse. 
 (PI3K) pathway, the pathway thought to 
control primordial follicle activation (John et al., 2009).  Expression of PI3K 
components following KL treatment supports the suggestion that the Kit 
system regulates follicle development and affects secretion of oocyte factors 
that regulate the primordial to primary follicle transition (Reddy et al., 2005).   
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2.2 MATERIALS AND METHODS 
Animals 
Laying hens (SCWL Babcock B300 strain), between 22 and 74 weeks 
of age were housed individually in laying batteries.  They had free access to 
feed and water and were exposed to 15 h light: 9 h darkness per day, with 
lights on at 0600 h.  Individual egg laying was recorded daily.  Hens with 
regular laying patterns were selected and euthanized at 1-2 h after 
oviposition in order to collect tissue samples.  All procedures were approved 
by the IACUC of Cornell University. 
Oocyte Conditioned Media (OCM)   
OCM was produced by dissecting very small follicles from the ovarian 
stroma.  These follicles, which were less than 1 mm in size, were pooled and 
incubated in M199 plus 0.1% BSA for 3 days in a humidified atmosphere 
containing 5% CO2
RNA Isolation 
 at 37°C for 3 days.  After 3 days the supernatant was 
collected, filter-sterilized (0.2 µm membrane), and frozen.  Many separate 
preparations of OCM were combined to create a large pool for subsequent 
use in cell culture (Johnson et al., 2008). 
Total RNA was extracted from ovarian body, liver, intact follicles (<1 
mm), and granulosa cell layers from different sized follicles (3, 5, 6-12 mm 
and F1) using the Qiagen RNeasy mini kit and following manufacturer 
instructions.  For more detailed analysis of expression, the granulosa layer 
was split so that one half contained the germinal disc (GD) and the other 
half consisted of non-germinal disc (NGD) granulosa cells (Johnson et al., 
2008).  Comparisons were then made between GD and NGD KL mRNA 
expression.   
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PCR Analysis 
Quantitative real-time PCR with Sybr Green was performed to 
quantify expression of KL, using 18S expression as an internal control for 
KL normalization.  Chicken-specific primers (GenBank accession #205130) 
designed to span intron regions were used (Invitrogen software program).  
These primers predicted a product of 133bp for KL (forward: 5’-
CCAGAGTCGCT GTCACAAAA-3’; reverse: 5’-
AGGCTGGAGCTGCTAATGAA-3’).  Control reagent was Ambion 
Quantum RNA Universal 18S primers (#1718) and controls were run for 
each sample.  A standard curve was created using serial dilutions of cDNA 
transcribed from a pool of granulosa cell RNA prepared from 6-8 mm 
follicles.  Control reactions lacking template and reverse transcriptase were 
also performed in parallel on each plate.  Relative RNA concentration was 
determined using the Ct
Granulosa Cell Culture 
 method as calculated by the ABI Prism 7000 
Sequence Detection System Software and the mean value for duplicate PCR 
amplifications was calculated relative to 18S reactions. 
Granulosa layers from 3-5 mm, 6-8 mm, 9-16 mm, F3/F4, and F1 
follicles were isolated and dispersed as described previously (Davis et al., 
1999).  Cell number and viability (>95%) were estimated with a 
hemocytometer.  Cells were plated in 6-well plates (in M199 plus 5% FBS) at 
a density of 3x106 cells/well in 1.5 ml volume and then incubated as 
described previously (Johnson et al., 2005).  After 24 h, medium was replaced 
with M199 plus 0.1% BSA as control.  Other treatments included OCM 
(10%, 25% or 50% of volume), FSH (0.1, 0.5, 1, 5, 10, 25 ng/ml; oFSH-19-
SIAFP), testosterone (0.1, 1, 10, 50 ng/ml), estradiol (0.1, 1, 10, 50 ng/ml), 
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progesterone (0.1, 1, 10, 50 ng/ml), Vitamin D3 
Medium was also size-fractionated using Amicon Ultra-15 centrifugal 
filter devices (Millipore; 35 min at 5000xg, 25°C) to separate OCM into two 
fractions of molecular weight less than and greater than 30 kDa.  In some 
experiments, OCM was pre-incubated with an antibody for 30 min at room 
temperature.  Antibodies used were against cKit (M14, Santa Cruz 
Biotechnology), BMP15 (GenScript, against chicken peptide sequence 
CLPGYLRDAGGDKSD), or GDF9 (JH131; obtained as a gift from Dr. S.-
J. Lee, Johns Hopkins University). 
(10, 100 nM) and 
recombinant mouse KL (25, 50, 100, 200 ng/ml; BioLegend, #579702).  
Pooled OCM was heat inactivated (30 min at 65⁰C) for characterization of 
OCM as described previously (Johnson et al., 2008).   
Granulosa Cell proliferation  
Granulosa cells were plated in 96-well plates at a density of 1.2x105
Theca Cell Culture 
 
cells/well in 100 µL of media and cultured as described above.  The number 
of viable cells was determined using the CellTiter 96 Aqueous One Solution 
Assay (Promega) according to manufacturer instructions.  Visual inspection 
of plate confluence confirmed proliferation. 
 The theca cell layer was isolated from 6-8 mm follicles.  For each 
repetition, the theca shells from one hen were pooled and cut up into small 
pieces.  Theca pieces were weighed and approximately equal weights (18-23 
mg) were allocated to wells in a 24-well plate with 0.5 ml of media.  Control 
treatments were M199 plus 0.1% BSA; other treatments were 25% or 50% 
OCM by volume, 25% OCM pre-incubated with an antibody to cKit (M14), 
cKit antibody alone, or recombinant mouse KL (50, 100, 200 ng/ml; 
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BioLegend, #579702).  After 24 h of incubation at 37°C in a humidified 
atmosphere of 5% CO2
Western Blot 
, medium was collected and frozen. 
Protein lysates were made from very small (<1 mm) follicles, F1 
granulosa cells, theca tissue from 3-5 mm follicles, and ovarian body.  
Protein concentrations were determined using a BCA Protein Assay Kit 
(Pierce) and 40 mg of total protein for each sample was loaded onto a 12% 
polyacrylamide gel (Pierce) along with a Biotinylated protein ladder (Cell 
Signaling).  Electrophoresis was performed under reducing conditions and 
the gel was transferred to a nitrocellulose membrane (Thermo Scientific).  
The membrane was blocked in 1X Tris-buffered saline with 0.1% Tween-20 
(TBST) containing 5% milk for 30 minutes at room temperature.  The 
membrane was washed and then incubated with a primary polyclonal 
antibody against mouse cKit (M14) at a dilution of 1:200 in TBST containing 
1% milk for 2 h at room temperature.  The membrane was washed and then 
incubated with a horseradish peroxidase conjugated donkey anti-goat IgG, 
(Santa Cruz #2020, diluted 1:2500) and an anti-biotin antibody (Cell 
Signaling, diluted 1:1000) in TBST containing 5% milk for 1h at room 
temperature.  The membrane was incubated with LumiGLO 
chemiluminescent substrate (KPL, Gaithersburg, MD) for signal detection 
and examined using a Fluor Chem HD2 Imager (Alpha Innotech). 
Radioimmunoassay 
 Culture media were collected and assayed to determine granulosa cell 
progesterone production or theca cell estradiol production.  Steroid 
hormone concentrations were estimated using Coat-A-Count 
radioimmunoassay kits for estradiol and progesterone (Diagnostics Product 
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Corporation, Los Angeles, CA).  The analytical sensitivity of the kits is 8.0 
pg/ml for estradiol and 0.02 ng/ml for progesterone.  Granulosa culture 
media was diluted 1:10 prior to assay.  For both assays, plasma from 
immature roosters was used as a low pool and plasma from ovulating hens 
treated with exogenous progesterone was used as a high pool.  Standards 
provided in the kit were assayed in triplicate and all culture media samples 
were assayed in duplicate.  The coefficient of variation (CV) for the 
progesterone assay was 6.8% and the mean CV for the estradiol assays was 
4.4%. 
Statistical Analysis 
Data were analyzed by the Statistical Analysis Systems (SAS) General 
Linear Model Procedure (Proc-GLM) with protected least-significant 
difference.  P values of <0.05 were considered significant, and means were 
compared using Duncan’s multiple range test.  Results are presented as 
means ± SE, percent of control, with different letters indicating significance 
at p<0.05. 
 
2.3 RESULTS 
Kit Ligand Expression with Follicle Development 
 After normalization to 18S expression, real-time PCR analysis (Figure 
2.1; n=4-5) indicated that KL mRNA expression decreased with increased 
follicle size (p=0.001).  KL mRNA was most abundant in preparations from 
very small (<1 mm) follicles, with high levels also found in the granulosa 
layer of 3 mm follicles and ovarian body.  The lowest levels of KL mRNA 
expression were found in the granulosa layer from 6-12 mm and F1 follicles, 
which did not differ from levels found in the liver tissue.   
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Analysis of KL expression from the GD and NGD regions of the 
granulosa layer of follicles 6 mm-F1 in size showed no significant difference 
between GD and NGD regions (Figure 2.2; n=2-5).   
 
Figure 2.1 KL mRNA expression during follicle development 
KL expression is highest in <1 mm follicles and granulosa cells from 3 mm 
follicles and decreases with follicle development, n=4-5; p<0.001. 
 
 
Figure 2.2 KL mRNA expression in GD vs. NGD granulosa cells 
KL expression did not differ between GD and NGD granulosa cells, n=2-5. 
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Regulation of KL by the Oocyte 
 Culture of granulosa cells from 6-8 mm follicles with 25% and 50% 
OCM increased KL mRNA expression in a dose-related way (Figure 2.3; 
n=4; p<0.05).  Pre-incubation of 25% OCM with antibodies against cKit 
(Figure 2.4; n=4), BMP15 (Figure 2.5; n=6) or GDF9 (Figure 2.6; n=2) 
did not block the stimulatory effect of OCM upon KL expression.  When 
OCM was separated into fractions by molecular weight, culture treatment 
with 25% OCM of high molecular weight (MW; >30 kDa) significantly 
increased KL expression (p<0.05) while low molecular weight (<30 kDa) 
OCM treatments had no effect (Figure 2.7; n=3).  KL mRNA expression 
was also examined following OCM treatments of granulosa cells from F1 
follicles (Figure 2.8).  25% OCM significantly increased KL mRNA 
expression in F1, an effect that was blocked by heat treatment (HT) of OCM 
prior to culture (n=3; p<0.01).     
 
 
Figure 2.3 KL mRNA expression after OCM treatment in granulosa 
cells from 6-8 mm follicles 
KL expression is significantly increased by treatments with OCM, n=4, 
p<0.05. 
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Figure 2.4 KL mRNA expression after OCM +cKit Ab treatment in 
granulosa cells from 6-8 mm follicles 
The antibody to cKit did not block the stimulatory effect of OCM on KL 
mRNA, n=4. 
 
 
 
Figure 2.5 KL mRNA expression after OCM +BMP15 Ab treatment in 
granulosa cells from 6-8 mm follicles 
The BMP15 antibody did not block the stimulatory effect of OCM on KL 
mRNA, n=6. 
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Figure 2.6 KL mRNA expression after OCM +GDF9 Ab treatment in 
granulosa cells from 6-8 mm follicles 
The antibody to GDF9 did not block the stimulatory effect of OCM on KL 
mRNA, n=2. 
 
 
 
 
Figure 2.7 KL mRNA expression after OCM treatment in granulosa 
cells (6-8 mm) treated with high and low MW OCM 
KL expression is significantly increased by high MW OCM and unchanged 
by low MW OCM, n=3, p<0.05. 
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Figure 2.8 KL mRNA expression after OCM treatment in  
granulosa cells from F1  
KL expression increased by OCM (p<0.01) is partially reduced by HT of 
OCM, n=3. 
 
Regulation of KL by Steroids 
 KL mRNA expression was assessed following granulosa cell 
treatment with various doses of steroid hormones.  Vitamin D3 (VD3) 
treatment significantly increased KL mRNA expression in granulosa cells 
from 6-8 mm (Figure 2.9; n=5-6; p<0.05) and 3-5 mm (Figure 2.10; n=4-5; 
p<0.01) follicles at the dose of 100 nM but had no effect at the 10 nM dose.  
Expression of KL mRNA in granulosa cells from 6-8 mm follicles treated 
with estradiol, progesterone, or testosterone was not significantly altered 
(data not shown).   
Additional Regulation of KL 
 Relative expression of KL mRNA from granulosa cells of 6-8 mm 
follicles was significantly decreased by FSH (Figure 2.11; n=4; p<0.05).  In a 
separate experiment, lower doses of FSH (0.1, 0.5, 1, 5, 10 ng/ml) had no 
effect on KL mRNA expression in granulosa cells from 6-8 mm follicles 
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(data not shown).  In contrast, KL mRNA expression in 9-16 mm granulosa 
cells was increased by FSH (data not shown; n=5; p<0.05). 
 
 
Figure 2.9 KL mRNA expression after VD3 treatment in 6-8 mm 
granulosa cells  
KL expression is significantly increased by treatment with 100 nM VD3, 
n=5-6, p<0.05. 
 
 
Figure 2.10 KL mRNA expression after VD3 treatment in 3-5 mm 
granulosa cells 
KL expression is significantly increased by treatment with 100 nM VD3, 
n=4-5, p<0.01. 
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Figure 2.11 KL mRNA expression after FSH treatment in granulosa 
cells from 6-8 mm follicles 
KL expression is significantly decreased by treatment with FSH (25 ng/ml), 
n=4, p<0.05. 
 
 
Figure 2.12 Western blot protein expression of cKit 
Protein bands are seen at the expected sizes of 125 kDa (precursor) and 140 
kDa (mature) in <1 mm follicles, theca (3-5 mm follicles), and ovarian body. 
Protein Expression of cKit 
 A representative western blot shows cKit protein expression in very 
small (<1 mm) follicles, the theca layer from 3-5 mm follicles, and ovarian 
body (Figure 2.12).  Two bands were found at the expected sizes: 125 kDa 
(precursor) and 140 kDa (mature).  cKit protein expression was not found in 
the granulosa layer from the F1 follicle.   
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Kit System Regulation of Steroid Synthesis 
 Progesterone (P4) production by cultured F1 (Figure 2.13; n=4; 
p<0.01) and F3/4 (data not shown, n=4; p<0.05) granulosa cells was 
significantly inhibited by treating with 10% OCM.  In both experiments, this 
effect was blocked by pre-incubating the OCM with an antibody to cKit, 
thought to bind soluble cKit present in the OCM.   
 Estradiol (E2) production by cultured pieces of theca from 6-8 mm 
follicles was increased by OCM in a dose-related way (Figure 2.14; n=5; 
p<0.05).  Addition of cKit antibody in an attempt to block the effect was 
not successful.  Additionally, pre-incubation of the OCM with cKit antibody 
further increased estradiol production to the level found with 50% OCM.   
In another experiment, E2 production from 6-8 mm theca pieces was 
not affected by treatment with KL at a variety of doses (Figure 2.15; n=4).   
Proliferation 
Various doses of KL had no effect on proliferation of cultured 
granulosa cells from 6-8 mm follicles (data not shown; n=3).    
 
Figure 2.13 P4 production by F1 granulosa cells after OCM treatment 
P4 production is significantly decreased by treatment with OCM. 
Preincubation with cKit antibody blocks the effect, n=4, p<0.01. 
A
B
A
A
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Control 10%OCM 10%+cKit cKit Ab
P4
 p
ro
du
ct
io
n;
 %
co
nt
ro
l
67 
 
 
Figure 2.14 E2 production by 6-8 mm theca cells after OCM treatment 
E2 production is significantly increased by treatment with 50% OCM, 
p<0.05.  Pre-incubation of 25% OCM with cKit Ab increases E2 production 
to levels seen with 50% OCM treatments, n=5. 
 
 
Figure 2.15 E2 production by 6-8 mm theca cells after KL treatment 
E2 production is not affected by treatment with KL at any dose, n=4.   
 
1.4 DISCUSSION 
To our knowledge, this is the first demonstration of a quantified 
pattern of KL expression in the hen ovary throughout follicle development.  
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This is also the first demonstration of cKit protein expression in the ovary 
of the hen.  Previous data have shown downregulation of KL by HB-EGF 
in the adult hen (Wang, 2007), but have not reported patterns of expression 
during follicle development or regulation by other factors.  KL may have a 
role in regulating the progression of follicles through the highly organized 
hierarchy seen in the hen ovary.  This is suggested by high levels of 
expression seen in the small follicles and lower levels seen in the selected 
follicles.  Data from several mammalian studies have indicated the 
importance of KL in follicle recruitment from the resting primordial follicle 
pool (mouse: Yoshida et al., 1997; hamster: Wang and Roy, 2004; cow: 
Parrott and Skinner, 1997; Muruvi and Fortune, 2009; goat: Celestino et al., 
2010).  Our quantitative PCR analysis showed the highest KL mRNA in very 
small intact follicles (<1 mm) and the granulosa layer from 3 mm follicles 
(Figure 1).  GD versus NGD granulosa KL expression was investigated 
based on studies in the mouse that found differences in expression between 
cumulus (low) and mural (high) granulosa cells in antral follicles.  Although 
the present study showed no difference in KL mRNA expression between 
GD and NGD granulosa from follicles of size 6 mm and larger, future 
efforts are needed in order to verify that there is no difference between GD 
and NGD granulosa cell KL mRNA in smaller follicles. 
Protein expression of cKit was shown to be present in the oocytes of 
very small follicles (<1 mm), in addition to the theca cell layer from 3-5 mm 
follicles and in ovarian body.  No protein bands were detected in the 
granulosa cell layer isolated from the F1 follicle.  This pattern of expression 
matches what has been found in mammals (mice: Motro and Bernstein, 
1993; Horie et al., 1991; sheep: Tisdall et al., 1999; goats: Silva et al., 2006; 
69 
 
pigs: Brankin et al., 2004; humans: Horie et al., 1991; Carlsson et al., 2006; 
cattle: Parrott and Skinner, 1997) with high levels of expression in theca and 
oocytes from preantral, growing follicles.  In the hen, follicles approximately 
8 mm in size or less represent the growing follicles, prior to follicle selection 
(Woods and Johnson, 2005). 
Based on previous reports in the mouse (Joyce et al., 1999; Joyce et al., 
2000), we examined whether the oocyte may affect the expression of KL 
mRNA.  Earlier work in the chicken showed that OCM treatments of 
granulosa cells from 6-8 mm follicles significantly decreased AMH mRNA 
expression (Johnson et al., 2008) and that GDF9 protein is present in OCM 
(Johnson et al., 2005).  In the current study, we found upregulation of KL 
mRNA expression by OCM in granulosa cells from 6-8 mm follicles.  
Treatment of 6-8 mm granulosa cells with high MW OCM increased KL 
mRNA, which leads us to believe the oocyte-derived factor involved in 
stimulation of KL has a weight greater than 30 kDa.  We also used heat 
treatment of OCM to verify that the effective component(s) in OCM 
was/were protein.  With this in mind, we performed further granulosa cell 
culture experiments using OCM pre-incubated with antibodies against cKit 
(to bind soluble cKit; 145 kDa), BMP15 (38 kDa), and GDF9 (32 kDa); all 
three antibodies detected chicken proteins at the appropriate sizes by 
western blot in our lab (GDF9: Johnson et al., 2005).  These attempts to 
block the effect of OCM were unsuccessful; the results are outlined below 
(Table 2.1).  The inability of these antibodies to block the effects of OCM 
on KL mRNA expression could be due to insufficient antibody 
concentrations, since the concentrations of factors found in OCM are  
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Table 2.1 Potential Oocyte Factors involved in the Regulation of KL 
Oocyte Factor Experiment Results: Effect on KL mRNA 
BMP15 OCM+BMP15 Ab; 
BMP15 treatments 
No effect 
GDF9 OCM+GDF9 Ab No effect 
cKit OCM+cKit Ab No effect 
EGF EGF treatments No effect 
Vitamin D3 VD3 treatments Increased 
E2, P4, T Steroid treatments No effect 
 
unknown.  Alternatively, the bioactivity in the OCM could be due to an 
untested factor. 
VD3 has been shown to significantly decrease anti-Müllerian 
hormone (AMH) mRNA expression and significantly increase follicle 
stimulating hormone receptor (FSHR) mRNA expression in hen granulosa 
cells from 6-8 mm follicles (Wojtusik and Johnson, 2010).  This suggested to 
us that it may modulate other factors involved in follicle selection and 
development.  In the current study, a high dose of VD3 stimulated KL 
mRNA expression in 3-5 and 6-8 mm granulosa cells.  This was the only 
example we found of steroid regulation of KL expression.  Furthermore, 
mRNA expression for the VD3 receptor (VDR) has been found in very 
small follicles (<2 mm; Wojtusik and Johnson, 2010), so it is possible that a 
portion of OCM effects on KL expression can be attributed to regulation by 
VD3, although this is unlikely since VD3 would have been in the low MW 
portion of OCM (Table 2.1).  The influence of VD3 on KL, AMH, and 
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FSHR indicates its importance in regulating factors involved in follicle 
development, although the exact mechanism of such actions is currently 
unknown. 
We investigated regulation of KL by FSH based on previous reports 
in the cow (Parrott and Skinner, 1998) and mouse (Joyce et al., 1999).  These 
studies demonstrated an increase of KL mRNA by FSH, while the current 
study found decreased KL mRNA expression in 6-8 mm granulosa cells with 
FSH treatment.  However, we did find an increase in KL mRNA in 9-16 mm 
granulosa cells by FSH.  These results suggest a differential effect of FSH 
with increased follicle differentiation, although this is difficult to reconcile 
because FSHR mRNA is reported to be at similar levels in follicles of 6-8 
and 9-16 mm (Woods and Johnson, 2005). 
Granulosa cell progesterone production was examined in large (F1, 
F3/4) follicles because they produce high levels of progesterone while theca 
cells from small follicles are the source of estradiol synthesis (Johnson, 
1996).  The ability of the cKit antibody to block the inhibitory effect of 
OCM on progesterone production suggests the existence of a soluble cKit 
isoform in OCM that binds and biologically activates KL.  This possibility is 
backed by the data showing the existence of soluble cKit in human follicular 
fluid (Tanikawa et al., 1998) and human endothelial cells (Broudy et al., 1994).  
These results suggest that the Kit system exhibits regulatory actions on 
steroid production from hierarchal follicles.  To our knowledge, this is the 
first report on the function of the Kit system in the ovary of an oviparous 
species.  This result, along with regulation of KL is depicted more clearly in 
Figure 2.16. 
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Figure 2.16 Actions of the Kit System in the hen ovary 
 
The capability of the cKit antibody to block the effect of OCM on 
progesterone suggested cKit may be involved in the stimulatory effect of 
OCM on estradiol production by the theca layer from 6-8 mm follicles.  This 
hypothesis is backed by literature suggesting regulatory effects of the Kit 
system in increasing P450 aromatase mRNA and protein expression (for a 
subsequent increase in E2 production) in the rat (Jin et al., 2005).   Instead of 
blocking the effect, however, pre-incubation of the cKit antibody with 25% 
OCM resulted in an additional increase in estradiol production.  This 
suggests that the antibody could neutralize the biological activity of soluble 
and thecal cKit, which might otherwise act to decrease estradiol production.  
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This could be an indirect effect following Kit system regulation of another 
factor, such as testosterone or aromatase.  In a different approach to 
examine Kit system regulation of estradiol in the hen ovary, we treated 6-8 
mm theca cultures with KL, but estradiol production was unaffected.   
KL did not increase proliferation of granulosa cells from 6-8 mm 
follicles, which contrasts with the proliferative effect of the Kit system on 
haemopoeitic cells (Hayman et al., 1993) and melanocytes (Lahav et al., 1994).  
Together with the finding that KL did not affect E2 production, these 
results may mean that recombinant mouse KL is not bioactive in the chicken 
ovary. 
Unfortunately, we were unable to determine protein expression of KL 
because there was no available antibody against chicken and other available 
antibodies were not recommended for use because of low homology with 
chicken KL.  Additionally, despite running various immunohistochemistry 
protocols and acquiring and using two separate lots of the cKit antibody 
(M14), we were unable to demonstrate specific localization of cKit protein in 
the ovarian follicle, as only autofluorescence was detectable.   
In interpreting the results from the present study, we can conclude 
that OCM contains one or more heat-labile, bioactive substances that play a 
role in regulating follicle development.  Although it is likely that this 
substance is oocyte-derived, it is important to point out that in the culturing 
of OCM, the entire follicle is present including granulosa and theca cells, so 
factors derived from these cells may be having effects of their own. 
Unfortunately, our study of the Kit system in the hen ovary was 
impeded by the lack of available bioactive reagents for use in the hen.  
Perhaps development of recombinant chicken KL as well as development of 
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specific antibodies against chicken cKit and KL, would alleviate the 
problems we had.  We cannot rule out the possibility that GDF9, BMP15 or 
cKit have a role in regulating the Kit system, because we cannot be sure if 
our reagents were able to block the actions of the bioactive proteins found in 
OCM, due to a mismatch between antibody and OCM concentrations.  On 
the other hand, the factor in OCM having effects on KL and estradiol may 
not be one of these proteins, and regulatory actions of other untested factors 
should be considered. 
Future experiments examining the function and regulation of cKit and 
KL in the ovary of the hen are necessary for a more complete understanding 
of follicle development.  The relationship between the Kit system and AMH 
would be interesting to study, given the contrasting roles they have in follicle 
recruitment (Yoshida et al., 2007; Durlinger et al., 1999; Durlinger et al., 
2002).  Additionally, we know that VD3 has opposite effects on mRNA 
expression of KL and AMH, so it is possible that there could be an 
interaction.  It would also be interesting to determine whether the Kit system 
is involved in the regulation of other steroids, such as testosterone, or 
regulation of other ovarian factors including GDF9 and BMP15.   
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CHAPTER 3 
ANTI-MÜLLERIAN HORMONE REGULATION OF FOLLICLE 
STIMULATING HORMONE RECEPTOR IN THE HEN OVARY 
 
3.1 INTRODUCTION 
Anti-Müllerian hormone (AMH, also known as Müllerian inhibiting 
substance, MIS), named for its role in regressing the Müllerian duct system 
in male mammals, has the same function in male birds, in addition to 
regressing the right Müllerian duct in female birds (Tran and Josso, 1977).  
Estrogen produced by the left ovary of birds protects the left Müllerian duct 
from regression, thereby permitting development of the left oviduct (Teng, 
2000; Teng, 2001).  Anti-Müllerian hormone has a well-defined function 
during embryonic development in mammals and birds but the function of 
this hormone in adult females is less clear. 
AMH is produced by the granulosa layer of growing follicles in 
females and is believed to be important in regulating the rate of recruitment 
from the primordial follicle pool as well as in regulating follicle stimulating 
hormone (FSH) sensitivity (Durlinger et al., 1999; Durlinger et al., 2001).  In 
mice, expression of AMH mRNA or protein is not seen in primordial 
follicles, oocytes or theca, and is first detected in granulosa cells of primary 
follicles (Ueno et al., 1989; Baarends et al., 1995; Durlinger et al., 2002).  
AMH is highest in preantral and small antral follicles, with greater expression 
in granulosa cells surrounding the oocyte and antrum, as compared to the 
mural granulosa cells, possibly reflecting functional differences between the 
cells (Ueno et al., 1989; Baarends et al., 1995; Durlinger et al., 2002).  AMH 
knock-out studies indicate the importance of AMH in normal ovarian 
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function.  Female knock-out mice appear normal and are fertile, (Behringer 
et al., 1994) but their ovaries exhibit greatly increased numbers of small, 
growing follicles, leading to premature depletion of primordial follicles 
(Durlinger et al., 1999).  These findings were supported by in vitro studies 
showing that murine ovaries cultured with AMH had 40% fewer growing 
follicles and lower α-inhibin mRNA expression (Durlinger et al., 2002).   
The sequence of chicken AMH is 52% similar to mammalian AMH in 
the biologically active C-terminal region.  In the female chick embryo, 
expression of AMH in the developing left ovary was found to gradually 
increase to its highest level at day 14 then decline to close to baseline by the 
day before hatching (Teng et al., 1987).  Characterization of the expression 
pattern of AMH throughout follicle development in the hen showed that 
granulosa cell mRNA for AMH is expressed at high levels in the small 
growing follicles but is decreased in the large hierarchical follicles (Johnson et 
al., 2008; Johnson et al., 2009).  Interestingly, the decline in AMH expression 
with increasing follicle size is associated with an increase in expression of the 
FSH receptor (FSHR) in the granulosa layer, a relationship which may 
regulate orderly follicle selection (Visser and Themmen, 2005).  FSHR 
expression increases around the time of selection of a follicle into the 
preovulatory hierarchy of the hen (Woods and Johnson, 2005). 
In the mouse, it was discovered that in vitro preantral follicle growth 
stimulated by FSH treatment was reduced with addition of AMH (Durlinger 
et al., 2001).  Furthermore, AMH-deficient mice given injections of FSH had 
higher numbers of growing follicles when compared to wild-type mice, 
demonstrating the inhibitory regulation by AMH on follicle activation 
(Durlinger et al., 2001).  The attenuation of FSH actions by AMH has also 
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been demonstrated in the rat ovary.  FSH-stimulated LHR mRNA and 
aromatase activity in cultured rat granulosa cells was blocked with the 
addition of AMH.  This is interesting because LHR and aromatase are 
markers of granulosa cell differentiation (di Clemente et al., 1994).  As this is 
a post-activation role, this suggests that AMH suppresses follicle recruitment 
in addition to follicle activation.  Furthermore, microarray analysis of AMH-
treated rat ovaries showed that AMH downregulated the TGFβ pathway 
which signals for processes including cell differentiation, angiogenesis and 
cell cycle regulation (Nilsson et al., 2007).  This study also showed that the 
stimulatory actions of kit ligand (KL) on the transition from primordial to 
primary follicles in whole ovary cultures was attenuated with addition of 
AMH to the culture treatments (Nilsson et al., 2007).   
With regard to the regulation of AMH in the hen ovary, it has been 
shown that AMH is not regulated in vitro by glucose or insulin, factors related 
to metabolic state (Johnson et al., 2009).  Additionally, expression of AMH 
mRNA was not influenced by estradiol or progesterone (Johnson et al., 
2008).  Little is known with respect to the function of AMH in the hen 
ovary.  Bioactive AMH, shown to be present in testis-conditioned medium 
(TCM) by western blot analysis, induced cell proliferation that was blocked 
when the TCM was preincubated with an antibody to AMH (Johnson et al., 
2009).  As knowledge of AMH regulation and function in the hen ovary is 
limited to these few studies, there is a need for further investigation of its 
actions and regulation in an oviparous species.  The objective of the present 
study was to determine if AMH has a direct effect on mRNA expression of 
FSHR in follicles before or after selection.  
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3.2 MATERIALS AND METHODS 
Animals 
Laying hens (SCWL Babcock B300 strain), aged between 22 and 74 
weeks were housed individually.  They had free access to feed and water and 
were exposed to 15 h light: 9 h darkness per day, with lights on at 0600 h.  
Individual egg laying was recorded daily.  Hens with regular laying patterns 
were selected and euthanized at 1-2 h after oviposition in order to collect 
tissue samples.  All procedures were approved by the IACUC of Cornell 
University. 
Testis Conditioned Media (TCM) 
TCM was produced by collecting testes from chick embryos aged 
between 12 and 14 days (di Clemente et al., 1992).  Two testes were cultured 
in a tube for 3 days in a humidified atmosphere containing 5% CO2
Granulosa Cell Culture 
 at 37°C 
with 0.5 ml Medium 199 plus 0.1% BSA.  At termination, the supernatant 
was collected, filter-sterilized (0.2 µm membrane) and frozen until many 
preparations were pooled together for use in culture (Johnson et al., 2009).  
Western blot analysis confirmed the presence of AMH in the medium 
(shown in Johnson et al., 2008).   
Granulosa cells from laying hen follicles (3-5 mm and 9-16 mm) were 
isolated and dispersed as described previously (Davis et al., 1999).  Cell 
number and viability (>95%) were estimated with a hemocytometer.  Cells 
were plated in 6-well plates (in M199 plus 5% FBS) at a density of 3x106 
cells/well in 1.5 ml volume and then incubated as described previously 
(Johnson et al., 2005).  After 24 h, medium was replaced and cells were 
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cultured for an additional 24 h in the presence of control medium (M199 
plus 0.1% BSA), 25% TCM, or 50% TCM by volume.  In some experiments, 
an antibody against AMH (#4055-2, Genex Bioscience Inc., Hayward, CA) 
in a 1:100 dilution in M199 + 0.1% BSA was incubated 1:1 by volume with 
TCM for 30 minutes at room temperature before use.  To determine cell 
proliferation, granulosa cells were plated in 96-well plates at a density of 
1.2x105
PCR Analysis 
 cells/well in 100 µl of medium and cultured as described.  The 
number of viable cells was quantified using the Aqueous One Solution Cell 
Proliferation Assay (Promega) according to manufacturer instructions.  
Visual inspection of plate confluence confirmed proliferation.  After culture, 
RNA was extracted from the granulosa cells for evaluation of RNA 
expression by quantitative PCR (Qiagen).  
Chicken-specific probes and primers for analysis of FSHR expression 
(70bp product; GenBank accession #U51097) were derived using ABI 
Primer Express Software as described previously (Johnson et al., 2008).  
TaqMan ribosomal RNA 18S primers and probe were the control reagents, 
and a control reaction for FSHR normalization was run for each sample.  A 
standard curve was created using serial dilutions of cDNA transcribed from 
a pool of granulosa cell RNA prepared from 6-8 mm follicles.  Control 
reactions lacking template and reverse transcriptase were also performed in 
parallel on each plate.  Relative RNA was determined using the Ct
 
 method as 
calculated by the ABI Prism 7000 Sequence Detection System Software and 
the mean value for duplicate PCR amplifications was calculated relative to 
18S reactions. 
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Theca Cell Culture 
 The theca cell layer was isolated from 3-5 mm and 6-8 mm follicles.  
For each repetition, the theca shells from one hen were pooled and cut up 
into small pieces.  Theca pieces were weighed and approximately equal 
weights (18-23 mg) were allocated to wells in a 24-well plate with 0.5 ml of 
media.  Control treatments were M199 plus 0.1% BSA; other treatments 
were 25% or 50% TCM by volume.  After 24 h of incubation at 37°C in a 
humidified atmosphere of 5% CO2
Radioimmunoassay 
, medium was collected and frozen. 
 Culture media were collected and assayed to determine granulosa cell 
progesterone production or theca cell estradiol production.  Steroid 
hormone concentrations were estimated using Coat-A-Count 
radioimmunoassay kits for estradiol and progesterone (Diagnostics Product 
Corporation, Los Angeles, CA).  The analytical sensitivity of the kits is 8.0 
pg/ml for estradiol and 0.02 ng/ml for progesterone.  For both assays, 
plasma from immature roosters was used as a low pool and plasma from 
ovulating hens treated with exogenous progesterone was used as a high pool.  
Standards provided in the kit were assayed in triplicate and all culture media 
samples were assayed in duplicate.  The coefficient of variation (CV) for the 
progesterone assay was 0.4% and the CV for the estradiol assay was 4.7%. 
Immunoneutralization of TCM 
An immunoprecipitation (IP) technique was used to precipitate AMH 
protein out of whole TCM solution.  50 µg of AMH antibody (Genex) was 
incubated with TCM (volume ranging 75 µl-200 µl) overnight at 4°C with 
constant agitation.  100 µl of Protein A resin slurry was added to the antigen-
antibody complex as the solid substrate for binding of the antibody, and the 
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mixture was incubated for 2 h at room temperature with constant agitation.  
IP buffer (TBS) was added, mixture was centrifuged for 3 minutes at 2500xg, 
and supernatant was removed.  This was repeated three times.  A reducing 
sample buffer (SDS, glycerol, Tris-HCL) was added to the complex-bound 
resin and incubated 5 minutes at 95°C.  The mixture was centrifuged for 3 
minutes at 2500xg to separate the resin from the immune complex in the 
eluate.  Gel electrophoresis was then performed using whole TCM as well as 
the initial supernatant and the eluate, followed by transfer to a nitrocellulose 
membrane.  The membrane was probed for AMH as previously described 
(Johnson et al., 2008). 
Statistical Analysis 
Data were analyzed by the Statistical Analysis Systems (SAS) General 
Linear Model Procedure (Proc-GLM) with protected least-significant 
difference.  P values of <0.05 were considered significant, and means were 
compared using Duncan’s multiple range test.  Results are presented as 
means ± SE, percent of control. 
 
3.3 RESULTS 
Presence of AMH in TCM 
 Western blot analysis confirmed the presence of immunoreactive 
AMH in TCM (Figure 2.1). 
FSHR mRNA Expression 
 In a preliminary experiment, FSHR mRNA expression was decreased 
in granulosa cells from 3-5 mm follicles with 25% and 50% TCM by volume 
(Figure 2.2; n=2; p<0.05).  In a subsequent series of experiments, pre-
incubation of 25% TCM with an antibody against AMH did not block the 
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inhibition of FSHR expression (Figure 2.3; n=8; p<0.05).  Similarly, using 
granulosa cells from 9-16 mm follicles, preliminary results demonstrated a 
decrease in FSHR mRNA expression when treated with 25% TCM (Figure 
2.4; n=5; p<0.05; 50% TCM was not used as a treatment).  In following 
experiments, pre-incubation of 25% TCM with an antibody against AMH 
did not block the inhibition of FSHR expression (Figure 2.5; n=8). 
 
 
Figure 3.1 Western blot confirming presence of AMH in TCM 
Protein from TCM (10 and 15 µg) was run and probed with AMH Ab. 
Approximate size of 70 kDa is indicated. 
 
 
Figure 3.2 FSHR mRNA expression after TCM treatment in granulosa 
cells from 3-5 mm follicles 
FSHR expression is decreased by treatments with TCM, n=2, p<0.05. 
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Figure 3.3 FSHR mRNA expression after TCM plus AMH Ab 
treatment in granulosa cells from 3-5 mm follicles 
FSHR expression is significantly decreased by treatments with TCM, effect is 
not blocked using an AMH Ab, n=8, p<0.05. 
 
 
 
Figure 3.4 FSHR mRNA expression after TCM treatment in granulosa 
cells from 9-16 mm follicles 
FSHR expression is decreased by treatments with TCM, n=5, p<0.05. 
 
A
B
B
B B
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Control 25%TCM 50%TCM 25%TCM+AMH 
Ab
AMH Ab Alone
FS
H
R
 n
or
m
al
iz
ed
 to
 18
S;
 %
co
nt
ro
l
A
B
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Control 25%TCM
FS
H
R
 n
or
m
al
iz
ed
 to
 18
S;
 %
co
nt
ro
l
90 
 
 
Figure 3.5 FSHR mRNA expression after TCM plus AMH Ab 
treatment in granulosa cells from 9-16 mm follicles 
There is no difference between control, 25%TCM, or 25% TCM plus AMH 
Ab, n=8, p<0.05. 
 
 
 
Figure 3.6 Proliferation of 3-5 mm granulosa cells 
Proliferation is significantly increased by treatment with 25% and 50% TCM, 
n=3, p<0.05. 
Proliferation 
 There was a dose-related increase in granulosa cell proliferation of 3-5 
mm follicles in response to treatments of 25% and 50% TCM (Figure 2.6; 
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n=3; p<0.05).  Similarly, granulosa cells from 9-16 mm follicles proliferated 
in response to 50% TCM treatment (Figure 2.7; n=7; p<0.05).  
 
Figure 3.7 Proliferation of 9-16 mm granulosa cells 
Proliferation is increased by treatment with 50% TCM, n=7, p<0.05. 
 
 
Figure 3.8 Estradiol production by 3-5 mm theca with TCM treatment 
Estradiol production was unaffected by treatment with TCM, n=6. 
Regulation of Steroid Production 
 Treatment with TCM had no effect on theca estradiol production by 
3-5 mm (Figure 2.8, n=6) or 6-8 mm follicles (Figure 2.9, n=6) at either 
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dose.  Progesterone (P4) production by granulosa cells from 9-16 mm 
follicles was significantly decreased by treatment with 25% TCM (50% TCM 
dose was not used).  Preincubation of TCM with an antibody to AMH was 
unable to block the inhibitory effect of TCM (Figure 2.10, n=6). 
 
Figure 3.9 Estradiol production by 6-8 mm theca with TCM treatment 
Estradiol production was unaffected by treatment with TCM, n=6. 
 
 
Figure 3.10 P4 production by 9-16 mm granulosa cells with TCM 
treatment 
P4 production is decreased by treatment with 25% TCM, n=6; p<0.001. 
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Figure 3.11 Western blot detecting AMH following 
immunoprecipitation 
Protein from whole TCM, IP supernatant (SN) and IP eluate was probed 
with AMH Ab. Approximate size of 70 kDa is indicated. 
 
Immunoneutralization of TCM 
 Following immunoprecipitation (IP) of AMH from TCM, a western 
blot probe was unable to confirm that AMH was removed from the 
supernatant and present in the eluate.  The appropriate band (found in the 
lane with whole TCM) was not seen in either the supernatant or the eluate 
(Figure 2.11). 
 
3.4 DISCUSSION 
 It is known that mammalian AMH is not bioactive in avian systems 
(di Clemente et al., 1992) and avian AMH is not commercially available.  For 
these reasons, we utilize TCM, a source of bioactive AMH for use in cell 
culture experiments (Johnson et al., 2008).  The presence of AMH protein 
was detected in TCM with western blot analysis, (Johnson et al., 2008) which 
was confirmed in the present study.   
70 kDa 
TCM    SN     Eluate 
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 The current study of the regulation of FSHR by AMH was based on 
previous reports in the mouse (Durlinger et al., 1999; Durlinger et al., 2001).  
TCM was consistently capable of downregulating granulosa cell FSHR 
mRNA expression in follicles before selection (3-5 mm) and follicles that 
were recently selected (9-16 mm).  Unfortunately, the current experiments 
were unable to demonstrate specificity of the results, since preincubation of 
TCM with an antibody against AMH was unable to attenuate the effect.  The 
stimulatory effect of TCM on granulosa cell proliferation from both groups 
of follicles provides evidence that the decrease of FSHR mRNA is not due 
to adverse effects on the granulosa cells. 
 Granulosa cell progesterone production was examined in 
differentiated (9-16 mm) follicles because they produce progesterone while 
theca cells from small follicles are the source of estradiol (Johnson, 1996).  It 
was predicted that the AMH found in TCM would inhibit P4 production, 
due to its direct and indirect actions in suppressing follicle recruitment in 
mice (Durlinger et al., 1999; Durlinger et al., 2001), cows (Cushman et al., 
2002), and rats (Nilsson et al., 2007), and since granulosa cell steroid 
production is correlated with follicle development (Johnson, 1996).  AMH 
was expected to inhibit estradiol production by the cultured pieces of theca, 
based on previous reports that FSH-stimulated aromatase activity in rat 
granulosa cells was decreased by AMH (di Clemente et al., 1994).  AMH 
inhibited P4 production by 9-16 mm granulosa cells, but had no effect on 
estradiol production by pieces of theca from 3-5 mm or 6-8 mm follicles, 
suggesting differential actions on steroidogenesis based on follicle stage or 
cell layer.  This may also provide evidence that the AMH receptor is present 
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in granulosa cells and not present in theca cells in the hen ovary, since the 
receptor has not yet been identified in the chicken. 
The present data imply that TCM contains a bioactive substance 
which regulates granulosa cell function in follicles before or after selection.  
This substance has the ability to consistently decrease FSHR mRNA 
expression and progesterone production by differentiated granulosa cells.  
The results we obtained by use of the AMH antibody suggest that this 
substance is not AMH.  However, it is possible that the antibody against 
AMH did not completely immunoneutralize the AMH present in TCM, as 
we have no way of quantifying the concentration in TCM in order to use the 
correct amount of antibody.  Another approach we have used to remove 
AMH from TCM was to incubate various volumes of TCM with 
immobilized antibody, in an IP technique.  Western blot analysis of the 
“purified” supernatant indicated that AMH may still be present, and showed 
no difference from the eluate.  This suggested that we were unable to 
estimate the appropriate amount of antibody to neutralize bioactive AMH in 
the TCM.  We intended to repeat this procedure with higher amounts of 
antibody to be sure all the AMH is bound, but we were restrained by the 
high cost of this particular antibody.  In the future, we may use a different 
antibody to bind the AMH in TCM and then use the supernatant (lacking 
free AMH) to treat cell cultures in order to demonstrate that the effect on 
FSHR mRNA is blocked.  If we succeed, this will demonstrate that 
suppression of FSHR mRNA is due to bioactive AMH in the TCM.  
Additional future experiments will further investigate the actions of AMH in 
the hen ovary, as FSHR may not be the only factor important for ovarian 
function that is regulated by AMH.   
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CHAPTER 4 
SUMMARY AND CONCLUSIONS 
 
 The overall goal of these studies was to investigate various factors 
involved in folliculogenesis in the hen ovary.  The two studies investigated 
two factors noted to have opposing regulatory actions on follicle activation: 
KL, which is thought to promote follicle activation, and AMH, known to 
inhibit follicle activation.  With respect to regulation and function, there has 
been little study of either factor in the hen ovary. 
The first study examined expression, regulation and function of the 
Kit system (composed of KL and its receptor, cKit) in the hen ovary.  We 
found a distinct pattern of KL mRNA expression throughout follicle 
development, with the highest expression seen in very small (<1 mm) 
follicles and granulosa cells from 3 mm follicles.  KL mRNA expression 
decreased in parallel with follicle development, with the lowest levels seen in 
6-12 mm and F1 follicle granulosa cells.  To our knowledge, this is the first 
demonstration of quantified KL mRNA expression during follicle 
development in the hen ovary.  Western blot analysis demonstrated protein 
expression of cKit in very small follicles, theca tissue from 3-5 mm follicles, 
and ovarian body.  cKit protein was not detected in granulosa cells from the 
F1 follicle.  To our knowledge, this is the first demonstration of cKit 
expression in the hen ovary. 
In our examination of KL regulation in the hen ovary, we found 
upregulation of KL mRNA expression by OCM in granulosa cells from 6-8 
mm follicles.  It was then discovered that this upregulation is specific to 
factors in OCM with molecular weights greater than 30 kDa.  Unfortunately, 
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we were unable to conclusively determine which factor(s) in OCM were 
having this effect on KL.  Our data would suggest that cKit, BMP15 and 
GDF9 were not involved, but we are not confident of the results, in light of 
the possibility that we might have failed to use an effective dose of antibody 
to counteract the factor in OCM. 
The first study also demonstrated steroid and gonadotropin regulation 
of KL mRNA expression.  Steroid regulation was found by treating 3-5 mm 
and 6-8 mm granulosa cultures with vitamin D3.  VD3 was shown to 
significantly increase KL mRNA expression in both sets of follicles.  In 
contrast, granulosa cell treatment with progesterone, estradiol and 
testosterone exhibited no effect on KL mRNA.  With regard to 
gonadotropin regulation, FSH demonstrated disparate effects.  In cultures of 
6-8 mm granulosa, FSH significantly decreased KL mRNA expression, yet 
KL expression was significantly increased in 9-16 mm granulosa cells. 
Function of the Kit system was demonstrated with regard to steroid 
production.  A decrease in progesterone secretion by granulosa cells from F1 
and F3/4 is hypothesized to be due to actions of soluble cKit found in 
OCM that binds and activates KL produced by granulosa cells.  This was 
shown when preincubation of OCM with cKit antibody blocked the 
decrease in progesterone production by treatment with OCM alone.   
We also found that KL does not affect estradiol synthesis by theca 
tissue from 6-8 mm follicles.  Additionally, granulosa cell proliferation from 
these follicles is not altered by treatment with KL.  However, these results 
may suggest that recombinant mouse KL is not bioactive in the chicken. 
In the second study, we examined the effects of bioactive chicken 
AMH (in the form of TCM) on granulosa cell mRNA expression of FSHR.  
101 
 
We found that TCM is consistently capable of downregulating granulosa cell 
FSHR mRNA expression in follicles before selection (3-5 mm) and follicles 
that were recently selected (9-16 mm).  Unfortunately, preincubation of 
TCM with AMH antibody did not block the decrease in FSHR mRNA, so 
we were unable to determine the specificity of this effect.  TCM was able to 
increase granulosa cell proliferation, which indicates that the downregulation 
of FSHR mRNA was not due to adverse effects of the TCM on the 
granulosa cells. 
 The second study also showed a significant decrease in granulosa cell 
progesterone production with treatment of TCM.  Again, this effect was not 
blocked by the antibody against AMH.  Our results show that TCM contains 
a bioactive substance which regulates granulosa cell function, and suggest 
that this substance is not AMH.  However, it is possible that the antibody 
against AMH did not completely immunoneutralize the AMH present in 
TCM, as we have no way of quantifying the concentration in TCM in order 
to use the correct amount of antibody. 
KL and AMH are thought to have essential and opposing roles in 
regulating the progression of follicles through the highly organized hierarchy 
seen in the hen ovary.  This is suggested by high levels of mRNA expression 
for both factors seen in the small follicles and lower levels seen in the larger 
selected follicles.  Clearly, additional work is needed to gain a more complete 
understanding of the function and regulation of both factors in the chicken 
ovary.  It is especially important to determine the interactions between KL 
and AMH, and whether or not they act to regulate one another.   
 
